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ABSTRACT 
Airway Basal Cells in Development, Injury-Repair, and Homeostasis 
Ying Yang 
 
Basal cells (BCs) are multipotent tissue-specific stem cells of a variety of organs including the skin, digestive 
and respiratory tract. BCs are broadly identified by expression of Krt5, Krt14 and the transcription factor 
p63. In the adult airways, BCs are not only important for normal maintenance but also crucial for epithelial 
repair after injury. However, the embryonic origin of these adult stem cells remains elusive. Previous reports 
showed that p63+ cells appear early during airway development, but these do not express markers of adult 
BCs, raising the question whether these cells represent BC precursors. Moreover, little was known whether 
embryonic BCs have an impact in the adult pool of progenitors that mediate responses of the lung to injury 
or pulmonary diseases. The goal of this thesis is to address these gaps of knowledge using a variety of 
technologies, including functional and lineage tracing analysis in vivo in mouse genetic models, injury 
modeling, high-throughput profiling and gene regulation approaches. 
This thesis is to comprehensively characterize airway BCs in development, injury-repair, and 
homeostasis. These studies revealed a previously unrecognized broader role of embryonic p63+ cells in 
the establishment of the stem cell pools of the lung pre and postnatally. Surprisingly, lineage analysis 
showed that early in development these cells were able to generate all epithelial cell types of the airways 
and alveolar compartment. However, as development proceeds, they underwent two sequential lineage 
segregation events to finally generate two regionally distinct adult stem cell pools. One of these became 
the well-known BCs that populate extrapulmonary airways through an undescribed maturation process from 
the perinatal stage to adulthood, and the other was identified as a rare stem cell pool in the pseudostratified 
epithelium of intrapulmonary airways which maintained immature and quiescent throughout lifetime. 
Moreover, the latter responded uniquely to lung injury induced by H1N1 viral infection. Recent studies have 
demonstrated that BC-like p63+ Krt5+ cell clusters (“Krt5+ pods”) are ectopically present in the areas of 
severe alveolar injury by H1N1 viral infection. The presence of these pods has been associated with 
pathological scars in several human pulmonary diseases including idiopathic pulmonary fibrosis (IPF) and 
acute respiratory distress syndrome (ARDS). However, their cellular origin has been intensely debated. 
This thesis showed that this rare progenitor pool is established during embryonic development when 
airways are still branching. Further characterization demonstrated a p63 gene dosage dependency in the 
specification/maintenance of this rare progenitor pool. By utilizing multiple lineage-tracing lines, an 
underappreciated diversity of this pool was revealed by showing a novel subpopulation carrying secretory 
lineage marker spatially restricted to intrapulmonary airways. Further molecular characterization and 
genetic manipulation of this rare progenitor pool may provide valuable cues to understand the pathogenesis 
about pulmonary disorders and to develop effective therapies. 
Moreover, the molecular signatures of tracheal embryonic E18.5 preBCs and adult TrBCs were 
generated through high-throughput profiling, which provided hints about the genetic regulation of airway 
BC maturation process and generated potential molecular landmarks for the in vitro ES/iPS cell 
differentiation towards airway BCs. In addition, single cell RNA-sequencing analyses revealed 
heterogeneity of adult BCs in the tracheal and esophageal epithelia. Lastly, candidate master regulators of 
their differentiation programs in homeostatic and metaplastic states were identified through unbiased 
systems biology algorithms, which will be further validated in functional assays in the near future. 
Taken together, the studies in this thesis comprehensively characterized airway BCs in development, 
injury-repair and homeostasis. This thesis work showed the newly identified p63+ airway progenitors before 
E10.5 are multipotent for all lung epithelial lineages and this multipotency gets restricted to proximal fate at 
E10.5. In the adult injury-repair, this thesis work for the first time revealed that the H1N1-induced Krt5+ pods 
are generated by bronchial p63+ Krt5- progenitors, which originate from a subpopulation of E13.5 
intrapulmonary p63+ progenitors. At homeostasis, this thesis work uncovered a previously 
underappreciated heterogeneity of BCs in both airways and esophagus, and provided molecular 
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Chapter 1. Introduction 
 
Basal cells (BCs) are multipotent adult stem cells of a variety of tissues, including skin, esophagus, olfactory 
and airway epithelia, salivary and mammary glands. BCs are named for their proximity to the underlying 
basal lamina. They share common markers, including transcription factor p63 (tumor protein 63; 
transformation related protein 63), intermediate filaments Krt5 (cytokeratin 5), Krt14 (cytokeratin 14), and 
transmembrane integrin receptors Itga6 (CD49f), Itgb4 (CD104) and nerve growth factor receptor NGFR 
(p75)1. Multiple studies indicate that tissue-specific BCs serve as adult stem cells with capacities to self-
renew and differentiate into other lineages of their tissue of origin, which underpins the importance of BCs 
in maintaining the integrity of distinct epithelia during homeostatic turnover and injury repair2-5.  
In the respiratory system, BCs account for about 6-30% in the pseudostratified epithelium in proximal 
airways depending on location. Bountiful data from in vivo lineage tracing (Krt5-CreERT2 and Krt14-
CreERT2) and in vitro cell culture (air-liquid interface culture and matrigel-embedded 3D organoid culture) 
have presented evidence that BC can self-renew in long term and differentiate into luminal multiciliated and 
secretory cells, fitting the definition of adult stem cells2,4,6. The stem cell features of airway BCs can be 
hijacked during diseases or injury-repair. Excessive self-renewal leads to basal cell hyperplasia, and with 
additional triggers, may result in tumor formation. Inappropriate differentiation can lead to disruption of the 
luminal lineage balance with overrepresentation of goblet cells, causing excessive production of mucus and 
physical obstruction of small airways7.  
While there has been a wealth of studies to characterize signaling pathways regulating the regenerative 
activities of airway BCs in adulthood, the embryonic origins of these adult stem cells remain elusive. 
Previous reports showed that p63+ cells appear early during airway development, however, these cells do 
not express canonical markers of adult BCs such as Krt5, NGFR8-10. Moreover, little was known whether 
embryonic p63+ cells have similar potential as adult BCs, and how they contribute to the stem cell pool and 
the luminal compartment of airways in development, adulthood, and respond to severe injury or pulmonary 
diseases. The goal of this thesis is to address these gaps of knowledge using a variety of technologies, 
including functional and lineage tracing analysis in vivo in mouse genetics models, injury modeling, high-
throughput profiling and gene regulation approaches.   
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1-1. Basic structure of the respiratory system 
The mammalian respiratory system is a highly complex tree-like network of branching tubules and a large 
alveolar compartment specialized for gas exchange, designed to facilitate air breathing for terrestrial 
adaptation. The trachea bifurcates into two main stem bronchi, which further branch into multiple 
generations of airways connected with alveoli at the most distal ends. The cellular composition and 3D 
organization vary along proximal-distal axis, fulfilling the distinct functions in not only air transport and gas 
exchange, but also mucociliary clearance and innate immune defense demanded during the interaction 
between our body and external environment11.  
The conducting airways are comprised of trachea, bronchi and bronchioles. Large airways (trachea, 
bronchi are lined with a pseudostratified epithelium, with the architecture becoming progressively simplified 
into columnar epithelium towards the terminal bronchioles (small airways)12. The major cell types in 
conducting airways are secretory club and goblet cells, multiciliated cells, neuroendocrine cells, BCs and 
recently identified rare cell populations including ionocytes, tuft cells, and brush cells13. The distribution of 
each cell type also varies regionally to maximize the performance of particular function. BCs are widely 
accepted as adult stem cells which proliferate and generate luminal lineages in homeostasis and injury 
response. Multiciliated cells, are characterized by expression of the forkhead transcription factor Foxj1 and 
acetylated α-tubulin, are more abundant in proximal areas. These cells are terminally differentiated, and 
project hundreds of motile cilia towards the airway lumen to move external particles or pathogens through 
synchronized beating as part of the mechanism of mucociliary clearance14,15. Secretory cells comprise a 
heterogeneous cell population which have abundant secretory granules, and express multiple 
secretoglobins, including Scgb1a1 (CC10/CCSP), Scgb3a2, Scgb3a1, mucins (Muc5ac, Muc5b) and play 
critical roles in oxidative stress reduction, innate immune response, and xenobiotic metabolism16,17,18. 
Pulmonary neuroendocrine cells sense the environmental cues and respond by orchestrating neural system, 
immune cells, and pulmonary epithelial cells through neuropeptide secretion19,20. They are marked by 
expression of proneural bHLH transcription factor Ascl1 (Mash1), Cgrp (Calcitonin), Pgp9.5 (Ubiquitin 
carboxy-terminal hydrolase L1, Uchl1) and others. Neuroendocrine cells generally form clusters (NEB, 
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neuroendocrine body, innervated by both afferent and efferent neurons) at the branchpoint of each airway 
generation. Others remain isolated and intermixed with multiciliated and secretory cells.  
In alveolar region, two major epithelial cell types are present, alveolar type 1 cell (AT1), and alveolar type 
2 cell (AT2). AT1 cells, marked by Pdpn (T1α), have extremely large size and cover more than 95% of the 
gas exchange surface. They undergo a non-proliferative two-step process, flattening and folding during 
development, to form remarkably thin cellular structure juxtaposing the alveolar capillary network21. AT2 
cells are cuboidal, intercalated with large AT1 cells. They produce surfactants, including surfactant-
associated protein C (Spc, Sftpc), and lipids to reduce the surface tension of alveoli.  
The respiratory systems in mice and human are largely conserved , but differ in their regional cellular 
composition. In humans, BCs are found throughout intrapulmonary airways, extending to terminal 
bronchioles. In mice, BCs are restricted to extrapulmonary airways including trachea and main stem bronchi, 
and are largely devoid in intrapulmonary airways. It is widely accepted that the mouse trachea can be used 
as a model to study human airway biology1,11. In addition, goblet cells are almost absent from the adult 
mouse airways. These differences between mouse and human respiratory system may underlie the 
changes in living environment and evolutionary adaptation.  
 
1-2. Development of the mouse respiratory system 
The mouse respiratory domain is established at E9.0, marked by induction of the homeodomain 
transcription factor Nkx2-1 in the ventral foregut endoderm. The patterning of foregut endoderm by BMP 
antagonist Noggin from dorsal notochord and BMP/FGF/WNT from ventral cardiac mesoderm specifies the 
ventral trachea and dorsal esophagus. Genetic manipulation of BMP signaling pathway affects this dorsal-
ventral patterning, as shown by foregut ventralization in Noggin mutants22 and dorsalization in Bmpr1a/b 
mutants23. Early studies using foregut culture suggested that different thresholds of FGF signaling from the 
cardiac mesoderm are critical for the specification of respiratory domain in the foregut patterning process24. 
The essential role of WNT signaling in this process is supported by the complete lung agenesis with no 
Nkx2-1 expression in the middle foregut of Wnt2/2b null mice. Moreover, activation of canonical WNT/β-
catenin signaling leads to ectopic lung endoderm fate in esophagus and stomach endoderm25,26. Additional 
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signaling pathways including SHH (Sonic hedgehog) and RA (Retinoic acid) have been suggested to be 
integrated with WNT, BMP and FGF in specification of the respiratory domain27-29.  
Currently, the only known existing marker of lung identity is Nkx2-130, which is not only expressed in lung, 
but also in thyroid and brain. An antagonized interaction between ventral Nkx2-1 and dorsal Sox2 has been 
revealed to be critical in the specification/maintenance of tracheal versus esophageal fates10,31.  
From E9.5, the ventral trachea and dorsal esophagus starts to separate, and this process is completed 
by E11.5, splitting the initial single-lumen foregut into two tubes32. The detailed mechanisms regulating this 
separation morphogenesis is still in debate. A “splitting and extension model” has been proposed based on 
live imaging of foregut cultures. The separation initiates from the site of lung bud outgrowth with a saddle-
like structure moving anteriorly and a nascent trachea and esophagus extending posteriorly33. Alternative 
models include the fusion of endodermal ridges in the midline32 and extension of a tracheoesophageal 
septum by formation of a mesenchymal condensation34. Failure of this separation leads to esophageal 
atresia with/without tracheoesophageal fistula (EA/TEF), which is a relatively common birth defect with high 
morbidity35. 
By E9.5, two primary lung buds evaginate from the ventral wall of foregut. This primary budding requires 
Fgf10-Fgfr2 signaling, as epithelial deletion of Fgfr2 phenocopies the mesenchymal disruption of Fgf10 and 
results in lung agenesis36-38. Secondary buds form at E10.5, with the first appearance of Spc expression in 
the tip region39, and the establishment of the lobation pattern of the right and left lungs. From E10.5, 
epithelial tubules undergo reiterative growth and budding, referred as branching morphogenesis, until 
approximately E16.5 to form the bronchial tree. Coupled with branching morphogenesis is proximal-distal 
patterning, which is crucial to specify the distal future gas-exchange domain and the proximal airway 
domain. The distal progenitors express transcription factor Sox9 (sex determining region Y-box 9) and Id2 
(inhibitor of DNA binding 2). Proximal progenitors express Sox2 and further differentiate into distinct airway 
lineages including secretory, multiciliated cells and others. Lineage tracing analyses using Id2-CreERT2 
and Sox9-CreERT2 provided evidence supporting that the epithelial progenitors in the distal compartment 
self-renew extensively and continuously generate proximal airway descendants in a centripetal fashion 
during branching morphogenesis. By E16.5, these distal progenitors no longer generate proximal cells, but 
instead become restricted to distal fate by differentiating further into AT1 and AT2 lineages40,41. Signaling 
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pathways such as BMP, WNT are shown to be crucial in fate specification or maintenance of distal 
progenitors42,43. The fate switch from distal progenitors to proximal airway progenitors is still poorly 
understood. Hippo/Yap pathway has been suggested to play key roles in this process. At the transition zone 
between Sox9+ distal domain and Sox2+ proximal domain, Yap undergoes a nucleocytoplasmic shift, and 
responds to proximalizing local cues, which ultimately leads to Sox2 expression and airway progenitor cell 
specification44,45. 
Still during the formation of branchial tree, airway progenitors which initiate differentiation program 
towards multiple airway epithelial cell lineages. By ~E12.5 to E14.5, progressive acquisition of secretory, 
multiciliated and neuroendocrine cell fate starts, marked by expression of Scgb3a2, Foxj1 and Ascl1, 
respectively. Notch signaling plays significant roles in this cell fate selection, and disruption of Notch leads 
to overrepresentation of multiciliated cells and neuroendocrine cells at the expense of secretory cells46-48.  
A single-cell RNA-sequencing analysis suggested that a bipotential progenitor population exists in the 
distal airways at E16.5 to form alveolar AT1 and AT2 lineages. These bipotential progenitors co-express 
markers for AT1 and AT2, and progressively branch into either AT1 or AT2 lineages from E16.5 to E18.549.  
 
1-3. Current understanding of airway BCs 
Airway BCs, marked by p63, Krt5, and Krt14 (~20% of mouse airway BCs express Krt14 in homeostasis), 
are considered as the major adult stem cells in the pseudostratified epithelium of mouse trachea. They are 
named for their proximity to basal lamina, and consist of ~20-30% of the total epithelium. Previous lineage 
tracing analyses using Krt14-CreER and Krt5-CreER (transgene) suggested that airway BCs self-renew 
and contribute to maintenance of luminal lineages (multiciliated and secretory cells)2,50. Isolated airway BCs 
from both mice and human can expand in vitro and differentiate into multiciliated and secretory cells in air-
liquid interface culture or 3D matrigel-embedded organoid culture2,51, further supporting the adult stem cell 
identity of airway BCs. Additionally, early xenograft studies demonstrated that rat tracheal BCs can 
reconstitute the denuded tracheas and give rise to fully differentiated mucociliary epithelium afterwards52. 
In response to injury by SO2, luminal cells die and detach from basement membrane, while BCs expand to 
cover the wound and quickly regenerate the whole epithelium in two weeks2,53. Immediately following injury, 
a functional segregation of airway BCs occurs. A subpopulation of airway BCs begin to express c-myb, 
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which further differentiate into multiciliated cells, while others express N2ICD, generating secretory cells 
following54. The importance of Notch signaling in this regenerative process has also been elucidated earlier 
using both in vivo genetic manipulation and in vitro organoid culture3. Additional regulators including IL-
6/STAT3 and Grhl2 (transcription factor Grainyhead-like 2) have been identified as key factors controlling 
cell fate selection from BCs to multiciliated versus secretory lineages53,55. 
The potential heterogeneity of airway BCs has been a topic of intense investigation. Long-term clonal 
analysis and mathematical modeling suggested that airway BCs comprise equal numbers of multipotent 
stem cells and committed precursors. 94% of basal stem cells undergo asymmetric division to produce one 
stem cell and one basal luminal cell (this population slightly upregulates Krt8, but still retain p63 and Krt5 
expression) in a hypothesized process called stochastic homeostasis. The basal luminal precursor further 
differentiates into a secretory descendant over the course of ~11 days. The secretory descendant then 
commits to differentiation towards multiciliated fate. Direct differentiation from BCs to multiciliated cells was 
considered as a negligible event4. Krt14 was proposed to be a marker of a unipotent stem cell population6, 
but this was not supported by the clonal analysis.  
The regulation of airway BC activities in homeostasis is important, as the stem cell features of this 
population can be hijacked during injury-repair and tumor initiation. In vivo genetic manipulation and in vitro 
culture studies revealed multiple signaling pathways as regulators of airway BC proliferation and 
differentiation. EGFR (epidermal growth factor receptor) activity, canonical WNT/β-catenin and YAP 
pathway serve as agonist to promote proliferation of airway BCs56-59, while Notch plays an antagonist role 
in BC self-renewal3. FGF signaling shows distinct effects through different receptors. Conditional deletion 
of Fgfr1 using Krt5-CreER driver enhanced airway BC proliferation60; in contrast, Fgfr2 deletion in Krt5+ 
adult BCs led to defect in self-renewal and differentiation, partially through regulating the key transcription 
factor Sox261. Furthermore, BMP and TGFβ signaling activity is suppressed in adult airway BCs in 
homeostasis, and this signaling inhibition has been exploited in in vitro cell culture to expand BCs with 
differentiation suppression62.  
In contrast to the extensive investigations on adult airway BC activities, not much was known about the 
BC ontogeny in part due to lack of genetic tools. The master regulator of BCs, p63, has been reported to 
start expression in ventral tracheal domain from E10.59,10. Another canonical BC marker Krt5 has been 
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reported to start expression in airway epithelium from E15.5. Even though by E18.5 p63/Krt5 double-
positive BC-like cells were identified in trachea, these cells do not express additional BC markers such as 
NGFR until after birth8. It is unclear whether these cells are direct precursors for adult BCs and whether 
they possess similar potentials as their adult counterparts. An in vitro colony expansion assay was 
performed, attempting to investigate the ontogeny of airway BCs. In this study, ITGB4hi preBCs were 
separated from the rest Nkx2-1+ epithelial cells, but no difference in colony-forming efficiency and 
mucociliary differentiation was identified9, ruling out the possibility that ITGB4hi preBCs were the only 
precursors for airway BCs. Overexpression of Fgf10 using R26-rtTA; Tet-Fgf10 after E12.5 leads to ectopic 
p63+ cells while Fgf10 mutants exhibit decreased p63+ cell number in lower trachea, underlying the 
importance of Fgf10 signaling in airway BC development63. Epigenetic remodeling also plays essential roles: 
Genetic deletion of Ezh2 in Shh-Cre; Ezh2 f/f animals results in advanced maturation of tracheal BCs 
(expression of Krt5 as early as E14.5) and ectopic appearance of p63+ Krt5+ cells in intrapulmonary airways, 
and this effect is partially explained by the repression of Igf1 (Insulin growth factor 1)64,65. Thus, it remains 
unclear when and how airway BCs are specified and how the embryonic progenitors contribute to this stem 
cell pool and the luminal compartment of airways in development.  
 
1-4. p63, the master regulator of BC identity in common 
p63 is a highly conserved homolog of p53 transcription factor family. It is predominantly expressed in BCs 
in the epithelia of multiple tissues, including epidermis, esophagus, olfactory epithelium and airway 
epithelium5,66,67. p63 is a regulator of BC identity, and it has been suggested to play essential roles in 
epithelial morphogenesis and maintaining stemness in progenitor cells by multiple loss-of-function 
studies5,68-70. 
p63 gene is located on chromosome 3 in human and chromosome 16 in mice. p63 is expressed from 
two promoters, producing two major isoforms TAp63 and ΔNp63. The full-length TAp63 contains a 
transactivating domain in the N-terminal, while ΔNp63 uses an alternative promoter in an additional exon 
3, resulting in a N-terminal truncated transcript version without the transactivating domain. TAp63 isoform 
is thought to be restricted primarily in the oocytes71, however recent studies uncovered that TAp63 may be 
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expressed to exert functions in skin development, ciliogenesis and early embryogenesis72-75. ΔNp63 is 
widely expressed in epithelial BCs, showing undoubted significance in epithelial morphogenesis.  
p63 null animals die immediately after birth, due to dehydration from defective skin development. Striking 
defects were also observed in limb, tail, craniofacial, and genital development68,69,76,77. Detailed examination 
in in vitro clonal assays and in vivo histology analyses revealed that p63 is essential to maintain the 
proliferative activity of epithelial stem cells in thymus and epidermis71. Additionally, whether p63 is essential 
for the epithelial stratification remains controversial, as conflicted results were presented from different 
groups71,77,78. Recent studies using hESC differentiation platform and genome-wide epigenetic mapping 
suggested that p63 is not required for the specification of epidermal lineage, but essential for the maturation 
process afterwards to functional keratinocytes79,80. Other than epidermis, the self-renewing capacity of 
mammary stem cells is also controlled by p63, specifically, ΔNp63, as loss of one functional allele of ΔNp63 
dramatically reduces the fat pad reconstitution efficiency and frequency of mammary stem cells81.  
In the airway epithelium, ΔNp63 is critical for the formation of BCs. Tracheal epithelium in p63 null 
animals exhibits simplified columnar architecture with no BCs instead of the pseudostratified structure. 
Intriguingly, the airway epithelium was found over populated by multiciliated cells at the expense of 
secretory cells when analyzed by immunohistochemistry for Tub4, a marker of motile cilia82. Conditional 
deletion of p63 from adult airway BCs using Krt5-CreER driver caused spontaneous differentiation of p63 
null cells towards luminal lineages, suggesting an essential role of p63 in maintenance of BC identity59. A 
lentiviral silencing of p63 in human airway BC culture led to decrease in proliferation and increase in cellular 
senescence83.  
 
1-5. Regionally distinct stem cell populations and injury-induced epithelial plasticity 
The lung epithelium is highly quiescent compared to other organs with high turn-over rate like esophagus, 
intestine, skin and hematopoietic system. The direct exposure to environmental agents and pathogens 
renders the lung sensitive for damage and calls for regenerative capacity. As epithelial cells are relatively 
immobile, and the cellular composition varies dramatically in distinct anatomic locations, different regionally-
specific stem cells are proposed to be responsible for the homeostatic maintenance and injury repair along 
proximal-distal axis.  
 9 
In the pseudostratified epithelium of extrapulmonary airways, BCs continuously self-renew and give rise 
to luminal multiciliated and secretory descendants2. In mouse intrapulmonary airways, BCs are largely 
devoid, and Scgb1a1+ secretory cells self-renew in long term and give rise to multiciliated cells in 
homeostasis and in injury such as naphthalene which kills the majority of the secretory cells84. Scgb1a1+ 
secretory cells do not contribute to the regeneration of alveolar lineages84. A subpopulation of secretory 
cell, preferentially identified as juxtaposed to NEBs and near the junction of terminal bronchioles with alveoli, 
is relatively resistant to naphthalene injury due to lack of Cyp2f2 (cytochrome p450). These cells express 
high levels of Upk3a, Scgb3a2 and low levels of CC10. They can repopulate the intrapulmonary airways 
after naphthalene injury and contribute slightly to alveolar regeneration after bleomycin injury16,85.  
In the alveolar compartment, AT2 cells are considered as adult stem cells. Lineage tracing analyses 
using Spc-CreER provided good evidence that AT2 cells self-renew in long term and give rise to AT1 cells 
in homeostasis86,87. In targeted AT2 injury by genetic expression of DTA (diphtheria toxin A) under Spc-
CreER driver, the surviving AT2 clonally expanded and generate both AT2 and AT1 cells86. AT2 cells are 
heterogeneous in WNT signaling activity. Two recent studies suggested that Axin2+ AT2 cells, a WNT 
signaling-active AT2 subpopulation, serve as the stem cells for the whole alveolar epithelial 
compartment88,89. The Axin2- AT2 cells can convert to Axin2+ progenitors in response to hyperoxia injury, 
as an autocrine secretion of Wnt2 from AT2 cells was induced, leaving the WNT-producing stromal niche 
dispensable88. However, in the accompanying report, this conversion was not observed, and Axin2+ AT2 
cells were solely responsible for alveolar regeneration after H1N1-induced acute lung injury89.  
Even though different regions in respiratory system can be maintained by the local resident stem cells 
which are considered more undifferentiated, reserved/facultative stem cells have been identified in different 
injury scenarios. Epithelial cells have under-appreciated plasticity. Differentiated cells might be recruited 
and fulfill the stem cell roles in specific injury challenges. For example, in extreme scenario that tracheal 
BCs were eliminated through genetic manipulation (Krt5-rtTA; tetO-DTA), secretory club cells were found 
to dedifferentiate into basal stem cell lineage and function as their endogenous counterparts in epithelial 
regeneration90. In addition, after partial pneumonectomy, unexpected conversion was considerably 
observed from terminally differentiated AT1 cells to AT2 cells, and this phenotypic switch from AT1 to AT2 
can also be recapitulated in in vitro 3D organoid cultures91. Pulmonary neuroendocrine cells were shown 
 10 
to generate secretory and multiciliated cells in CGRP-CreER lineage tracing after naphthalene injury92. 
Such plasticity is a universal phenomenon adopted in multiple epithelia, best studied in intestine. In intestine, 
Lgr5-expressing CBCs (crypt base columnar cells) continuously self-renew and generate secretory cells 
and absorptive enterocytes in homeostasis93. But when CBCs are genetically ablated, Bmi1+ cells located 
at the +4 position of each crypt can dedifferentiate into CBCs to restore homeostasis94. Irradiation can even 
induce acquisition of stem cell features in the Paneth cells through activation of Notch signaling95.  
Another event in epithelial plasticity is the recruitment of stem cells from neighboring tissues or domains. 
In the respiratory system, this phenomenon was illustrated by the fate interchange between submucosal 
gland (SMG) stem cells and surface airway epithelial (SAE) stem cells. SMGs are small epithelial 
appendages composed of ducts and acini embedded in the interstitial layer of the upper conducting airways. 
The stem cell population in SMGs, Acta2 (α-SMA)+ Krt5+ Krt14+ basal-like myoepithelial cells, serves as 
reserve stem cells for the SAE, recruited from the SMG microenvironment whenever necessary to 
regenerate both basal and luminal compartments in the SAE96-98. The descendants derived from SMG 
myoepithelial cells migrate into injured SAE, and gradually adopt airway BC features, presumably through 
microenvironmental reprogramming. Such microenvironmental reprogramming has been reported in thymic 
epithelial cells that adopt a hair follicle progenitor fate following epidermal transplantation99. The recruitment 
of stem cells from an adjacent region to repair a damaged epithelium depleted of its own stem cell pool has 
also been reported in interfollicular and hair follicle stem cells100.  
An intriguing acute lung injury model using H1N1 influenza virus infection was initially thought to be 
another example of this stem cell recruitment phenomenon. The H1N1 influenza virus induces wide-spread 
damage of both conducting airways and the alveolar compartment. Catastrophic epithelial destruction, as 
well as massive infiltration of immune cells, could be detected during 4dpi (days post injury) and 15dpi. The 
mice suffer from extreme weight loss from 4dpi but can gradually recover from 11dpi onwards. In the initial 
study, the lungs were thought fully recovered without fibrosis, eliciting the intriguing hypothesis that a novel 
adult stem cell population exists inside the lung with marvel regenerative potential. Since the 
characterization of this injury model in 2011, there have been heated debates, as a large number of p63-
expressing Krt5+ basal-like cells were found ectopically in the highly damaged lung parenchyma at 11dpi. 
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These p63+ Krt5+ cells formed discrete clusters, referred as Krt5+ pods, were proposed to serve as stem 
cells, responsible for the regeneration of damaged airways and alveoli101.  
Extensive lineage-tracing studies have been performed in the past few years, aiming at the cellular origin 
of these Krt5+ pods. DASCs (distal airway stem cells), double-positive for p63 and Krt5, were found in 
peribronchiolar region before injury. Lineage tracing using a Krt5-CreERT2 transgenic line labeled this 
population, and showed robust labeling in the Krt5+ pods post injury102. Another group using Scgb1a1-
CreERT2 lineage tracing line suggested the Krt5+ pods might be derived from secretory cells and these 
pods further regenerate AT1 and AT2 cells103,104. However, these lineage tracing strategies suffered from 
a caveat of tamoxifen persistence, as tamoxifen administrated through intraperitoneal injection may not be 
cleared within 3 weeks or even as long as 1 month. Additionally, the Scgb1a1-CreERT2 line can label a 
considerable AT2 population in homeostasis84. The marker used for describing AT1 regeneration, Pdpn, is 
shared by airway BCs, leading to the misunderstanding of alveolar regeneration in the initial studies. 
Chapman group using multiple CreERT2 knock-in lines for stringent lineage tracing analysis, found minimal 
contribution to Krt5+ pods from either Spc+ AT2 cells or CC10+ secretory cells, and 13% of Krt5+ pods 
bearing the Krt5-CreERT2 lineage label. The putative migration of extrapulmonary airway BCs into the 
injured lung was excluded by their lung transplantation experiments. LNEPs (lineage-negative epithelial 
progenitors, defined as EpCAM+ CC10-lineage- CD104+ CD200+ CD14+ isolated from distal airways) were 
proposed as the major source for Krt5+ pods based on the cell transplantation assay105. The potential 
contribution from AT1 lineage was further excluded in Hopx-CreERT2 lineage tracing. But Sox2-CreERT2 
labeled robustly the ectopic Krt5+ cells after injury, restricting the cellular origin of Krt5+ pods in proximal 
airways106. Until recently, a follow-up study from Chapman group showed that the Krt5+ pods were derived 
from a resident p63 lineage positive population in distal bronchioles. The Krt5+ pods persisted in long term 
and did not result in regeneration of any alveolar structures, unless Notch or WNT signaling pathways were 
genetically manipulated107. The persistence of ectopic Krt5+ pods was also associated with pathological 
scars identified in human pulmonary disorders including ARDS (acute respiratory distress syndrome) and 
IPF (idiopathic pulmonary fibrosis), further confirming the significance of deep understanding of the biology 
of these cells.  
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Chapter 2. Methods & Materials 
 
2-1. Mice 
p63-CreERT2 mice were generated and characterized as described in Lee et al. 2014108. This mouse line 
was originally in FVB background, with the CreERT2 coding sequence knocked into exon 4 which is shared 
by both deltaNp63 (major isoform in airway system) and TAp63 transcripts. Sox9-CreERT2, Spc-CreERT2, 
Upk3A-CreERT2, N3-CreERT2 knock-in lines have been previously reported and were currently used for 
lineage tracing of embryonic distal lung epithelial progenitors (Sox9109), adult alveolar type II cells (Spc87), 
adult secretory cells associated with neuroendocrine bodies and terminal bronchioles (Upk3A85), Notch3-
expressing mesenchymal and rare scattered epithelial cells (N3110), respectively. The CC10-CreERT2 
knock-in line was purchased from the Jackson Laboratory (B6N.129S6(Cg)-Scgb1a1tm1(cre/ERT)Blh/J)84, 
and was currently used to follow the fate of adult club and Spc+ CC10+ bronchioalveolar progenitor cells. 
All knock-in lines were bred into R26-tdTomato (Jackson Laboratory, B6.Cg-Gt(Rosa)26Sortm14(CAG-
tdTomato)Hze/J) for lineage-tracing analyses. All studies were approved by Columbia University 
Institutional Animal Care and Use committees (IACUC). 
    For time-pregnancy experiments, male mice from CreERT2 driver lines were mated with female mice 
from the R26-tdTomato reporter line. Noon of the day when the vaginal plug was identified was determined 
as E0.5. The developmental stages of TM administration for each lineage-tracing experiment were detailed 
below. 
For adult lineage-tracing experiments, 6-8 week-old mice were used and both male and female were 
included. Details about TM administration and H1N1 infection were described below. 
 
2-2. Tamoxifen Induction of Cell-Lineage Tracing 
2-2a. Lineage Tracing in Embryonic Development 
Tamoxifen (TM) was dissolved in sunflower seed oil (Sigma, T5648 and S5007) and administered by 
gavage to pregnant mice. To allow survival and analyses of postnatal stages, E18.5 embryos were 
transferred to adult CD1 foster mothers. 
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    To determine the efficiency of recombination at different TM doses and developmental stages we treated 
p63-CreERT2; R26-tdTomato mothers with TM by oral gavage at gestation days 13.5 (160 mg/g body 
weight), 14.5 (80 mg/g), 17.5 (70 mg/g) and analyzed lungs after 24hr. IF and quantitative analysis showed 
efficient recombination with the percentage of lineage-labeled p63+ tracheal cells averaging 35.7% ± 4.5%, 
54.3% ± 1.6%, and 95.6% ± 1%, respectively (post hoc Tukey’s test: E13.5 vs. E14.5 **adjusted P<0.01; 
E14.5 vs. E17.5 ***adjusted P<0.001; E13.5 vs. E17.5 ****adjusted P<0.0001.). Higher recombination 
efficiency was achieved at later developmental stages in spite of the lower TM doses, consistent with the 
overall increase in p63 expression levels perinatally. 
    TM-independent recombination in mice treated with vehicle at E13.5 and examined at E18.5 and 
postnatal P21 averaged <0.1% and 1.3% ± 0.5 of the p63+tdTomato+ tracheal cells, respectively. 
    To test for potential TM residual effects, we treated p63-CreERT2; R26-tdTomato E13.5 mothers with 
decreasing TM doses (160 μg/g, 10 μg/g and 4 μg/g body weight), looking for changes in the proportion of 
lineage-labeled cells in the basal versus luminal compartments at E18.5. Analysis of E14.5 tracheas 
confirmed the major dose-dependent decrease in recombination efficiency in p63+ cells, from 35.7% to 6.3% 
and 0.6%, respectively. By E18.5 the significantly higher proportions of p63+ tdTom+ in total tdTom+ cells 
were found at lower doses (43%, 56%, 57%, respectively; post hoc Tukey’s test: 160 μg/g vs. 10 μg/g 
**adjusted P<0.01; 160 μg/g vs. 4 μg/g **adjusted P<0.01; 10 μg/g vs. 4 μg/g non-significant P>0.05. This 
scenario would be unlikely in the presence of sustained recombination and thus argued against a TM 
residual effect. 
    For labeling p63+ cells before E14.5, we treated p63-CreERT2; R26-tdTomato mothers with 160 μg/g 
Tm by oral gavage (TM exposure at E8.5, E9.5, E10.5, E12.5 or E13.5). 
To label Sox9+ multipotent lung tip cells, we exposed Sox9-CreERT2; R26-tdTomato mothers with 160 
μg/g TM by oral gavage at E9.5 or E11.5. Lungs were examined at E15.5 or E17.5. 
2-2b. Lineage Tracing in Adult for H1N1 Injury Response 
For lineage tracing in adult animals in H1N1-infected lungs, 6-8 -week-old p63-CreERT2, CC10-CreERT2, 
p63+/+, Spc-CreERT2, Upk3A-CreERT2, N3-CreERT2 (male and female, all with R26-tdTomato reporter 
allele) mice were given 240 μg/g body weight TM in 5 sequential days via oral gavage. A chase period of 3 
weeks was used to prevent artefactual tamoxifen residual activity before viral infection. 
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2-2c. Lineage Tracing in Adult for BC isolation 
To efficiently and specifically label BCs in both trachea and esophagus in adult animals, 6-12 -week-old 
p63-CreERT2; R26-tdTomato mice were give 240 μg/g body weight TM once via oral gavage. A short chase 
period of 2-3 days was used to ensure accumulation of tdTomato in BCs and to minimize tdTomato labeling 
in luminal descendants. 
 
2-3. Histology and Immunostaining 
Embryonic and neonatal lungs were fixed in 4% paraformaldehyde in PBS at 4°C for 1 hour (earlier than 
E14.5), 4 hours (E14.5, E15.5), overnight (E18.5 and older; whole embryos). Adult lungs were inflated with 
4% paraformaldehyde (25cm water column pressure) through trachea and fixed overnight. Samples were 
processed for frozen or paraffin-embedding. 
    Immunofluorescence (IF) was performed in tissue sections (6-8mm) blocked with 10% horse serum and 
0.3% TritonX-100 (Sigma) for 1 hour at room temperature (rt). Primary antibodies were incubated in 1% 
bovine serum albumin (Sigma) and 0.3% TritonX-100 at 4°C overnight or 2 hours at rt. Sections were then 
washed with PBS and incubated with Alexa Fluor-conjugated secondary antibodies (1:500) and NucBlue 
Live Cell ReadyProbes Reagent (DAPI) (Life Technology) for 1 hr. After washing, samples were mounted 
with ProLong Gold antifade reagent (Life Technology). When necessary, antigen unmasking was done 
using Citric Based solution (Vector Labs H-3300) heated in microwave. Mouse primary antibody staining 
was done using M.O.M kit (Vector Labs BMK-2202). Whole-mount IF was performed using same reagents 
with elongated antibody incubation time. Confocal Microscopy was performed using a Zeiss LSM 710 
confocal microscope. 
    For visualization of labeled antibodies in immunohistochemistry (IHC), Mouse on Mouse Elite Peroxidase 
kit (Vector Labs, PK-2200) and Vectastain Elite ABC-HRP kit (Vector Labs, PK-6100) were used. To block 
endogenous enzyme activity, 0.3% hydrogen peroxide in 0.3% horse serum was used. Following DAB 
staining, Alcian Blue staining was performed. Images were acquired on a Nikon Labophot 2 microscope 
equipped with a Nikon Digital sight DS-Ri1 charge-coupled device camera. 
    The following primary antibodies were used: rabbit anti-p63a (1:400, CST, 13109); chicken anti-Krt5 
(1:500, Biolegend, 905901); rabbit anti-Krt5 (1:500, Biolegend, 905501); chicken anti-GFP (1:1000, Abcam, 
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ab13970); chicken anti-Krt8 (1:500, Abcam, ab107115); goat anti-CC10 (1:150, Santa Cruz, sc-9772); 
mouse anti-Ki67 (1:300, BD Biosciences, 550609); mouse anti-Ecad (1:100, BD Biosciences, 610181); 
mouse anti-Foxj1 (1:100, eBioscience, 14-9965); mouse anti-acetylated a-tubulin (1:2000, Sigma, T7451); 
rabbit anti-acetylated a-tubulin (1:500, CST, 5335); rat anti-Scgb3a2 (1:100, R&D, MAB3465); rabbit anti-
Cgrp (1:1000, Sigma-Aldrich, C8198); rabbit anti-Sox9 (1:500, Millipore, AB5535); goat anti-Sox9 (1:200, 
R&D, AF3075); rat anti-Sox2 (1:200, eBioscience, 14-9811-82); hamster anti-Pdpn (1:50, Developmental 
Studies Hybridoma Bank); rabbit anti-proSpc (1:1000, Seven Hills, WRAB9337); mouse anti-SSEA1 (1:50, 
Santa Cruz, sc21702); rabbit anti-Nkx2.1 (1:100, Abcam, ab76013); rabbit anti-Notch3 (1:50, CST, 5276). 
The following secondary antibodies were used: donkey anti-rabbit (conjugated with Alexa Fluor 488, 568, 
647); donkey anti-chicken (conjugated with Alexa Fluor 488); goat anti-chicken (conjugated with Alexa Fluor 
488, 647); donkey anti-goat (conjugated with Alexa Fluor 488, 568, 647); donkey anti-mouse (conjugated 
with Alexa Fluor 488, 568, 647); donkey anti-rat (conjugated with Alexa Fluor 488, 647); goat anti-hamster 
(conjugated with Alexa Fluor 647). All secondary antibodies were purchased from Thermo Fisher Scientific 
or Jackson ImmunoReseach. 
 
2-4. EdU Incorporation 
Analyses of cell proliferation in lineage-labeled cells was performed by exposing p63-CreERT2 pregnant 
mice to tamoxifen at designated stages through oral gavage and simultaneous intraperitoneal (i.p.) injection 
of EdU solution (1mg, 5mg/ml stock solution in PBS). EdU incorporation was assessed 24hr later in frozen 
tissue sections using the Click-iT EdU Alexa Fluor 647 Imaging kit (Thermo Fisher, C10340). Sections were 
then double-labeled with antibodies against selected cell markers using immunofluorescence. 
 
2-5. Quantitative Real-time PCR 
Whole tracheas were isolated (below the cricoid cartilage to carina) from p63-CreERT2/p63-CreERT2 KO 
and p63+/+ WT animals at E18.5. RNA was extracted using QIAcube and QIAGEN RNeasy Mini Kit. cDNA 
was synthesized using the SuperScript IV First-Strand synthesis system (Thermo Fisher). Gene expression 
was assessed using TaqMan Fast Universal PCR Master Mix (Applied Biosystems) and analyzed on a 
Step-One Plus instrument (Applied Biosystems). At least 4 tracheas were analyzed for each group. qRT-
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PCR in whole tracheal homogenates ensured that conclusions from analysis of tissue sections were not 
influenced by sampling biases due to regional distribution of these cell types. 
 
2-6. Fluorescence Intensity Profile Analysis 
For E14.5, 150 cells from epithelium were randomly picked, circled around nuclear shape (DAPI). 
Fluorescent intensity and area (mm2) for each cell was measured by Zen 2.3 lite software. 9 cells from non-
epithelial tissue without non-specific signals were picked and measured as negative control. The intensity 
value of p63 channel per unit area for each epithelial cell was calculated, and adjusted background by 
subtracting the averaged p63 intensity value per unit area of negative controls. The normalized values of 
p63 intensity per unit area lower than 3.6 were scored as p63 negative; values between 3.6 to 20.0 were 
scored as p63 low; values higher than 20.0 were scored as p63 high. The percentiles of cells with different 
p63 fluorescent intensity were shown in the graph. 
 
2-7. Quantification of Epithelial Cell Number per Unit Basement Membrane Length 
20 lines along the basement membrane on cartilage side from each E18.5 WT and KO samples were drawn 
with their length recorded in Zen 2.3 lite software. The numbers of epithelial cells above the basement 
membrane lines were quantified. The bar graph showing the averaged number of epithelial cells per unit 
basement membrane length (mm). N=3 for both WT and KO. In total, cells along 7.13mm basement 
membrane were counted in WT; cells along 6.91mm basement membrane were counted in KO. 
 
2-8. Foregut Culture 
Foreguts were dissected from E8.5 p63-CreERT2; R26-tdTomato embryos (8 to 13 somites), exposed to 
4-OHT (Sigma-Aldrich, H7904) for 2hrs and cultured on 6-well transwells (Costar 3450-Clear) in serum-
free differentiation medium111 supplemented with 0.02% Ascorbic Acid at 37C with 5% CO2. Cultures were 




2-9. H1N1 (PR8) Viral Preparation and Infection 
The influenza-A (H1N1) mouse-adapted PR8 viral stock was prepared and amplified in 10-day-old 
embryonated chicken eggs. Allantoic fluid containing the virus was collected two days after egg inoculation, 
cleared from cellular debris by centrifugation, aliquoted and stored at -80°C for further use. The viral titer 
was determined as 1.2x109 pfu/ml by plaque assay on Madin Darbin Canine Kidney cells using tenfold 
dilutions of allantoic fluid containing the virus. LD50 was initially determined in Balb/c mice as 450pfu. 
Different doses were tested in pilot experiments using WT C57Bl/6 mice, and 120pfu was found to achieve 
maximal generation of Krt5+ pods with minimal mortality rates in both WT and p63-CreERT2 mice. 
Adult mice (2-3 months old) were anesthetized by isofluorane, and then intranasally administered with 
120pfu of H1N1 virus diluted in 30ml PBS. Mock-infected animals received 30ml PBS. Successful infection 
was verified by weight loss and microscopy of lung frozen sections (massive infiltration of neutrophils and 
severe destruction of alveolar and airway structures). 
 
2-10. Epithelial Cell isolation and FACS analysis 
Tracheas and esophagus were isolated from adult mice with brief cleanup of stromal tissues. To isolate 
tracheal epithelial cells, only the main tracheal region below cricoid cartilage and above bifurcation was 
used to avoid confounding p63+ cells from larynx or mainstem bronchi. Tracheal tubes were cut open and 
digested in Dispase Digestion Solution (16U/ml Dispase (Corning, 354235) + 10μg/ml DNase I diluted in 
PBS) at room temperature for 40min. Digestion was stopped by transferring tracheas to PBS. Epithelium 
was physically peeled off with forceps, and collected in Falcon tubes. Further digestion into single cells was 
done in Trypsin Digestion Solution (0.1% Trypsin + 3mM EDTA diluted in PBS) at 37°C for 10min. To isolate 
esophageal epithelial cells, the muscle layer surrounding esophageal epithelium was physically peeled off, 
following with Trypsin digestion of epithelium at 37°C for 10min. Digestion was stopped by addition of FACS 
buffer (HBSS + 2% BSA + 1x GlutaMax) with 10% FBS, followed by gentle pipetting and passage through 
70μm cell strainer.  
To stain for cell sorting, cells were suspended in staining buffer (FACS buffer + 10μg/ml DNase I), and 
incubated with antibodies for 40min at 4°C. Cells were washed with FACS buffer and DAPI was added to 
a final concentration of 1.25μg/ml before sorting. Sorting was performed on Influx (BD Biosciences) and 
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data analyzed with Flowjo (version 10). Cells were collected in staining buffer. The following antibodies 
were used: CD104-BV510 (1:50, BD Biosciences, 743079), EpCAM-APC (1:100, eBioscience, 17-5791-
82), Lineage cocktail-Alexa Fluor 700 (1:20, Biolegend, 133313).  
 
2-11. Bulk RNA sequencing and data analysis 
BCs were isolated from adult mouse trachea and esophagus, E18.5 tracheal preBCs were isolated from 
embryonic tracheas, and these cells were sorted by DAPI- Lin- EpCAM+ CD104hi tdTomato+. For each 
replicate, three to five adult mice were pooled together for cell collection. For E18.5 tracheal preBCs, about 
6 to 10 embryonic tracheas from 3 to 5 litters were pooled together for each replicate. 6 replicates for each 
cell population were sorted individually and prepared for sequencing. RNA was extracted using Direct-zol 
RNA MicroPrep kit (Zymo Research, R2060). RNA integrity was confirmed by Bioanalyzer. Samples with 
RNA integrity numbers >9.0 were sent for sequencing.  
The sample numbers were: adult tracheal BCs (CY001, CY004, CY005, CY010, CY011, CY012); adult 
esophageal BCs (CY002, CY003, CY006, CY013, CY014, CY015); E18.5 tracheal preBCs (CY007, CY008, 
CY009, CY016, CY017, CY018). Library preparation and RNA sequencing were performed by JP 
Sulzberger Columbia Genome Center. mRNAs were enriched using poly-A pull-down from total RNA 
samples. Library preparation was conducted using Illumina TruSeq RNA prep kit.  
For CY001-CY006, libraries were sequenced using Illumina HiSeq4000 at Columbia Genome Center, 
which yielded target number of single-end 100bp 25-30 million reads for each sample. RTA (Illumina) was 
used for base calling and bcl12fastq2 (version 2.17) was used for converting BCL to fastq format, coupled 
with adaptor trimming.  
For CY007-CY018, libraries were sequenced using Illumina NovaSeq 6000 at Columbia Genome Center, 
which yielded target number of paired-end 100bp 20 million reads for each sample. RTA (Illumina) was 
used for base calling and bcl12fastq2 (version 2.20) was used for converting BCL to fastq format, coupled 
with adaptor trimming.  
For all samples (CY001-CY018), a pseudoalignment was performed to a kallisto index created from 
mouse transcriptome GRCm38 using kallisto (0.44.0). Differential gene expression analysis was performed 
using the R package Sleuth, and visualized in volcano plots. Specifically, Eso- and Tr-specific over-
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expressing genes, as determined and highlighted in the volcano plots, were used as GSEA gene sets to 
determine Eso- and Tr-scores in single cells, as described in the following section. 
 
2-12. Single cell RNA sequencing and data analysis 
Cells were sorted into staining buffer and stored on ice until proceeding to the 10X Genomics single cell 
platform at Columbia Genome Center. Single Cell 3’ libraries were prepared using the Chromium Single 
Cell 3’ v2 Protocol (CG00052) according to the manufacturer’s manual (10X Genomics). The pooled, 3’-
end libraries were sequenced using Illumina HiSeq4000. Cell Ranger version 2.1.1 was used for primary 
data analysis, including demultiplexing, alignment, mapping, gene expression quantification, dimension 
reduction analysis and clustering analysis within individual datasets. Specifically, for alignment and 
mapping, the mm10 reference genome and corresponding annotation were used.  
    For secondary protein activity analysis, single cell gene regulatory networks, including esoBC- and trBC-
specific ones, were constructed using the ARACNe algorithm112. ARACNe was run with 100 bootstrap 
iterations using 1813 transcription factors and 969 transcriptional cofactors. Parameters were set to zero 
DPI (Data Processing Inequality) tolerance and MI (Mutual Information) p-value (using MI computed by 
permuting the original dataset as null model) threshold of 10−8. Protein activity profiles were predicted using 
the VIPER algorithm113 based on individual ARACNe network, or using the metaVIPER algorithm114 based 
on both esoBC and trBC ARACNe networks. For protein activity-based clustering analysis, iterClust115, 
iterative clustering algorithm, was used. 
    For tertiary cross-datasets analysis, single cell gene expression matrices generated from primary 
analysis were combined, followed by tSNE (t-Distributed Stochastic Neighbor Embedding) dimension 
reduction analysis and DBSCAN (Density-based Spatial Clustering of Applications with Noise) clustering 
analysis. Eso- and Tr-scores were quantified using GSEA analysis, with Eso- and Tr-specific over-
expressing genes as gene sets. Such over-expressing genes were determined from bulk RNA-Seq analysis, 
as described in the previous section. 
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2-13. Quantification and Statistical Analysis 
Quantification and statistical analysis have already been detailed in the Methods section above, associated 
with each experiment, as well as in the figure legends. All quantification for colocalization and marker 
analyses were performed in Adobe Photoshop CS6. Statistical analyses were performed in Microsoft Excel 
or GraphPad Prism 7. As shown in figure legends, data in graphs were shown in mean ± SEM. Statistical 
significance of differences in three or more groups of data were determined by one-way ANOVA and post 
hoc Tukey’s test. Statistical significance of differences between two groups of data were determined by 
unpaired two-tailed t test.  
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Chapter 3. Two Sequential Lineage Segregation Events of p63+ Progenitor Cells 
During Airway Development 
 
3-1. p63 expression pattern in mouse respiratory system development 
p63 gene shows distinct expression pattern in tracheal epithelium during airway development. Before E14.5, 
p63 is broadly and weakly expressed in majority of tracheal epithelial cells (~70%). These cells are 
considered as immature p63+ Krt5- cells as they do not have characteristic features of mature BCs (Figures 
1A-B; Figure 2B). Moreover, they are identified in both luminal and basal locations, so they are different 
from the ITGB4hi prebasal cells described before9. The p63 signal intensity vary greatly among these cells, 
suggesting a remarkable heterogeneity in the early p63+ progenitor population (Figure 1C). E15.5 
represents a critical transition time point as some p63+ cells begin to express Krt5 at low levels and gradually 
change the nuclear polarity, being described as nascent preBCs. This is the first time that morphological 
segregation between basal versus luminal compartments is evident, and about 60% of total epithelial cells 
are positive for p63 signal (Figures 1A-B). From E16.5 to E18.5, relatively high level of p63 is co-expressed 
with Krt5 in the cells (~24% of total epithelial cells) which assume basal location with horizontal nuclear 
orientation (Figures 1A-B). These cells were referred as preBCs to distinguish from their postnatal 




Figure 1. Dynamics of p63 expression pattern in tracheal development. 
(A) Segregation of basal and luminal compartments in the pseudostratified trachea, expression pattern 
analysis of p63 (green peaks) and Krt5 (red peaks) in both basal and luminal locations at E14.5, E15.5 and 
E18.5. Orange arrow showing luminal p63+ cells with high intensity signals. Cyan arrow showing basal p63+ 
cells with high intensity signals. (B) Graph showing % p63+ cells in tracheal epithelium at indicated stages. 
(C) Graph showing % p63-expressing cells with variable fluorescence intensities at E14.5 from 150 
randomly selected epithelial cells in trachea. Scale bars: 10μm. 
 
To identify the onset of p63 expression in respiratory progenitors (marked by Nkx2-1), we searched for 
the earliest p63-expressing cells during initiation of trachea/lung development in Nkx2-1-GFP embryos in 
which the earlies Nkx2-1+ cells could be detected using GFP expression. Immunofluorescence (IF) first 
detected a lot of p63+ cells intercalated within the GFP+ respiratory domain at E9.0 before the evagination 
of primary lung buds (Figure 2A). At E9.5, when the two primary lung buds evaginated from the ventral 
foregut, a small population of p63+ GFP+ cells were found in the tracheal primordium and the scattered 
proximal regions of the early lung buds (Figure 2A). A day later p63+ GFP+ cells were mostly confined to 
the tracheal region, where it remained abundant in subsequent stages (Figures 2A-B). Therefore, the onset 
of p63 expression in lung development was  determined not from E10.5, but instead from E9.010, and a 





Figure 2. Unexpected early p63 expression in the respiratory domain. 
(A) Immunofluorescence (IF) of E9.0, E9.5 and E10.5 Nkx2.1-GFP embryos; boxed areas enlarged in right 
panels. GFP+ p63+ cells in lung (cyan arrows) or tracheal (white arrow) primordia. (*) GFP+ p63- in lung. (B) 
Whole-mount IF of E12.5 trachea & lung (left) and E14.5 trachea (right). Scale bars: 10μm unless noted. 
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3-2. preBCs at E18.5 give rise to adult BC pool in trachea and generate SMGs 
preBCs at E18.5 in tracheal epithelium are characterized by a well-defined basal layer of strongly labeled 
p63+ Krt5+ cells (Figure 3A). To determine whether preBCs have similar potentials as their postnatal 
counterparts, we performed lineage tracing using p63-CreERT2; R26-tdTomato mouse line with TM 
administration at E17.5 by oral gavage, and followed the fate of lineage-labeled preBCs at different 
postnatal stages (Figure 3A). Exposure of p63-CreERT2 embryos to TM at E17.5 labeled 96% of the p63+ 
Krt8- preBCs at E18.5 and labeling frequency was maintained high throughout adulthood (postnatal days 
P7, P21) (Figures 3B & C). Labeled luminal cells (p63- Krt8+ tdTom+) increased significantly to 23% of the 
total tracheal epithelium at P21, confirming that the E18.5 lineage-labeled prebasal cells self-renew and 
simultaneously generate luminal descendants, resembling their postnatal BC counterpart (Figures 3B & C). 
Therefore, preBCs are direct precursors of adult BCs and they have higher turnover rate to accommodate 




Figure 3. E18.5 preBCs generated adult BC pool and simultaneously contributed to luminal 
compartment during postnatal growth. 
(A) Labeling of E18.5 preBCs in p63-CreERT2; R26-tdTomato mice with TM exposure at E17.5. (B) IF of 
tracheal sections showing tdTom labeling in p63+ Krt8- basal compartment and p63- Krt8+ luminal 
compartment at E18.5, P7 and P21. (C) Left graphs: % tdTom+ p63+ cells in total p63+ population; right 
graphs: % tdTom+ p63- cells in total p63- population at each stage. Graphs: mean ± SEM from 6-12 fields 
per sample, N≥3 per stage. Statistics: one-way ANOVA, *P<0.05; ****P<0.0001. Scale bars: 10μm. 
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SMGs are small epithelial appendages embedded in the interstitial layer of the SAE. Although in mice, 
SMGs are restricted to the most proximal part of trachea, in humans they were found throughout the 
cartilaginous airways deeply inside the lung. SMGs are derived from progenitors reside in the SAE during 
postnatal development116. Initially progenitor cells in Sox2+ PGPs (primordial glandular placodes) receive 
stimulatory signals such as WNT/β-catenin, evaginate into the stroma and further branch into the network 
of SMG117. However, which specific cell types in the SAE give rise to SMG in development remains 
unknown. To explore the ontogeny of SMGs, airway preBCs at E18.5 were hypothesized as the precursors 
for SMGs. The lineage tracing strategy was described above with TM exposure at E17.5 (Figure 4A). 
preBCs in SAE at E18.5 were specifically and efficiently labeled. At E18.5, tdTomato already labeled p63+ 
PGP-like structures in the upper trachea (Figure 4B). At P7 and P21, extensive labeling was observed in 
the nascent airway SMGs (which are double positive for both Nkx2-1 and Sox2), supporting the hypothesis 
that SMGs are derived from p63+ preBCs in SAE at E18.5 (Figure 4C & D). This developmental relationship 
between SMGs and SAE BCs may underlie the remarkable cellular plasticity of SMG myoepithelial cells in 




Figure 4. E18.5 preBCs in trachea generated SMG during postnatal growth. 
(A) Lineage tracing of p63-CreERT2; R26-tdTomato embryos with TM exposure at E17.5. (B-D) IF of top 
tracheal sections showing tdTom labeling in developing SMGs.  
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3-3. Tracheal BC pool is established at E13.5 by a subpopulation of p63+ cells 
To investigate the ontogeny of tracheal BCs, lineage tracing of p63+ progenitors was performed at distinct 
embryonic stages, and the lineage-labeling frequencies for E18.5 preBCs were evaluated, which further 
gave rise to adult BC pool. In spite of differences in recombination from E17.5 tracing, TM at E13.5 or E14.5 
both resulted in labeling of >84% of the E18.5 p63+ Krt8- prebasal cells. This could be ascribed to the strong 
p63 promoter activity in some of these cells (Figures 5 & 6). The data suggested that the pool of multipotent 
precursors destined to become BCs was largely established around E13.5, even preceding the appearance 
of Krt5, one of the earliest markers of initiation of BC program (Figures 5A & 6A). Consistent with this, TM 
exposure before E13.5 resulted in markedly reduced number of p63+ tdTom+ cells at E18.5 (ex. only 57.9% 
± 10.6% with TM treatment at E12.5). Interestingly, the labeling frequency in luminal compartment analyzed 
at E18.5 increased significantly when mice were exposed to TM at earlier stages (TM at E14.5: 18.1% ± 
1.9%; TM at E13.5: 33.7% ± 3.2%), suggesting that at least some of the p63+ tdTom+ cells could have been 




Figure 5. E15.5 nascent preBCs generated adult BC pool and contributed significantly to luminal 
compartment during postnatal growth. 
(A) Labeling of E15.5 preBCs in p63-CreERT2; R26-tdTomato mice with TM exposure at E14.5. (B) IF of 
tracheal sections showing tdTom labeling in p63+ Krt8- basal compartment and p63- Krt8+ luminal 
compartment at designated stages. (C) Left graphs: % tdTom+ p63+ cells in total p63+ population; right 
graphs: % tdTom+ p63- cells in total p63- population at each stage. Graphs: mean ± SEM from 6-12 fields 
per sample, N≥3 per stage, except P7 (N=2). Statistics: one-way ANOVA, *P<0.05; ****P<0.0001. Scale 
bars: 10μm. 
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Figure 6. Immature p63+ Krt5- progenitors labeled at E13.5 gave rise to majority of preBCs at E18.5 
and contributed significantly to luminal compartment in the meanwhile. 
(A) Labeling of E14.5 immature p63+ Krt5- progenitors in p63-CreERT2; R26-tdTomato mice with TM 
exposure at E13.5. (B) IF of tracheal sections showing tdTom labeling in p63+ Krt8- basal compartment and 
p63- Krt8+ luminal compartment at designated stages. (C) Left graphs: % tdTom+ p63+ cells in total p63+ 
population; right graphs: % tdTom+ p63- cells in total p63- population at each stage. Graphs: mean ± SEM 
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from 6-12 fields per sample, N≥3 per stage. Statistics: one-way ANOVA, *P<0.05; ***P<0.001. Scale bars: 
10μm. 
 
Next, to investigate whether the population of p63+ tdTom+ cells expanded preferentially compared to 
the other cell types, EdU was administered simultaneously with TM to p63-CreERT2 embryos at E13.5, 
E14.5, and E17.5 and incorporation was quantified 24hr later in p63+ tdTom+ or tdTom-, and p63- cells. As 
expected, EdU incorporation declined with age in all groups (Figure 7A). Interestingly, no evidence of 
preferential EdU incorporation was found in any of the p63+ populations (Figure 7A). Therefore, p63 
expression does not confer proliferative advantage at least in the developing trachea. The data also suggest 
that the above lineage labeling was not biased towards a higher proliferative p63+ subpopulation.  
This lineage tracing data suggested that BC precursors were preferentially labeled over luminal 
progenitors with TM administration at E13.5. There are two potential explanations for this result. One is that 
newly specified BCs continue to undergo Cre-mediated recombination due to a TM residual effect. The 
second explanation is that the recombination events predominantly occurred in BC precursors, due to their 
high p63 promoter activity. To distinguish between these possibilities, TM dose was reduced (from 160 μg/g 
body weight to 10 μg/g and 4 μg/g) to minimize residual effect; this resulted in major decrease in efficiency 
of labeling at E14.5 from 35.7% to 6.3% and 0.6%, respectively (Figures 7B). However, analysis of E18.5 
tracheas showed that in spite of the reduced recombination efficiencies at lower doses, the relative 
percentiles of tdTom+ p63+ BCs in the total lineage-labeled population were consistently increased (Figure 
7B). These suggested that BC precursors are preferentially labeled in this lineage tracing system, but not 
due to TM residual effect. Thus, the airway BC pool is established by a group of p63+ progenitors 
presumably with relatively higher p63 promoter activity at E13.5, earlier than the morphological segregation 




Figure 7. E13.5 tracing preferentially labeled BC precursors, not due to labeling bias of proliferative 
activity or TM residual effect. 
(A) p63-CreERT2; R26-tdTomato mice exposed to EdU and TM simultaneously at E13.5, E14.5 or E17.5. 
EdU incorporation and lineage-labeling analysis in tracheal sections after 24hr: p63+ (tdTom+ or tdTom-) or 
p63- cells (representative images and quantification). (B) TM titration experiment showed dramatic 
decreased recombination efficiency with decreased TM dosage. However, the labeling frequency of basal 
compartment increased significantly with lower TM dosage, excluding the possibility of TM residual effect. 
Statistics: one-way ANOVA, **P<0.01; ***P<0.001; n.s. non-significant. Scale bars: 10μm.  
 
3-4. Embryonic p63+ progenitors contribute equally to secretory and multiciliated lineages during 
tracheal development 
To further investigate the contribution from p63 lineage to multiciliated and secretory lineages, E13.5 tracing 
was analyzed during embryonic development, as the confounding conversion from secretory to multiciliated 
lineage is limited.  When pregnant mice were exposed to tamoxifen at E13.5, 34% of total luminal cells 
carried the lineage-label at E18.5 (Figure 6C). Interestingly, quantification for the lineage-labeled Foxj1+ 
multiciliated cells and CC10+ secretory cells showed similar proportions (37% for multiciliated lineage while 
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36% for secretory lineage) (Figure 8A). This indicated that lineage-labeled embryonic p63+ cells underwent 
a balanced differentiation program, as they made comparable contributions to multiciliated and secretory 
lineages during development.  Furthermore, E14.5 tracing showed a significant increase in the lineage-
labeled A-tub+ or CC10+ luminal cells at late prenatal and postnatal stages (Figure 8B). Thus, embryonic 
p63+ progenitors make equal and considerable contributions to luminal secretory and multiciliated lineages 
during tracheal development. 
 
 
Figure 8. Lineage restriction of p63+ cells contributed equally to multiciliated and secretory lineages 
in developing trachea. 
 34 
(A-B) Immunofluorescence (IF) of tracheal sections from p63-CreERT2; R26-tdTomato mice. Contribution 
of embryonic p63 to luminal tracheal secretory and multiciliated cells pre- and postnatally. TM exposure at 
E13.5 or E14.5 and analysis at E18.5, P0-P21. tdTom double-labeled with differentiation marker; dotted 
area shown as single channel in lateral panels or insets. Graph: % tdTom+ cells in multiciliated and secretory 
cells at E18.5. Graph: mean ± SEM from 6-12 fields per sample, N≥3 per stage. Statistics: Student’s t test, 
n.s. non-significant. Scale bars: 10μm. 
 
3-5. p63+ progenitors at the onset of lung specification are multipotent to generate both airway 
and alveolar lineages 
As described above, p63-expressing progenitors are already present in the primitive respiratory domain at 
the onset of lung specification since E9.0. To lineage-trace p63 at the earliest stages observed, E8.5, E9.5 
or E10.5 embryos were exposed to TM (160 μg/g, maternal oral gavage). Analysis of E18.5 tracheas 
showed extensive tdTom labeling in the pseudostratified epithelium at these stages, confirming the 
contribution of these progenitors from as early as E8.5 (Figures 9A & B; 10A-D). Intrapulmonary airways 
were nearly unlabeled in E10.5 TM-treated embryos (Figure 9B). Surprisingly, TM exposure at E9.5 or E8.5 
resulted in abundant tdTom+ cells in E18.5 intrapulmonary airways extending ectopically to alveolar 
saccules (Figures 9A & 10D). IF showed tdTom+ cells double-labeled with markers of airways (CC10: 
secretory; Cgrp: neuroendocrine) and alveolar (Pdpn: type I; pro-Spc: type II) cells (Figures 9A & 10D). 
E8.5 TM-treated embryos showed the broader distribution of tdTom+ cells extending to the lung domain at 
different stages from E9.5-E18.5 (Figures 9A-D). To rule out putative TM residual effect in vivo, E8.5 foregut 
explants from p63-CreERT2; R26-tdTomato embryos were isolated, treated with 4-hydroxytamoxifen (4-
OHT) for 2hrs and subsequently cultured for 5 days. IF showed the ectopic tdTom extending to the distal 
Nkx2.1+ Sox9+ domain of lung buds, confirming the pattern observed with E8.5 TM administration in vivo 
(Figure 9E). Thus, in the early respiratory tract, p63 marks multipotent progenitors able to generate 
potentially proximal and distal epithelial cell components, as predicted for other progenitors occupying the 





Figure 9. p63 labels multipotent progenitors of airways and alveoli and later become lineage-
restricted to airways. 
p63-CreERT2; R26-tdTomato lineage labeling. E18.5 trachea (top panels) and lungs (bottom panels: 
intrapulmonary airways and alveolar saccules) from embryos exposed to TM at E9.5 (A) or E10.5 (B). 
tdTom+ double-labeling with cell type-specific differentiation marker: insets depict secretory (CC10), 
neuroendocrine (Cgrp), alveolar type 1 (Pdpn) and type 2 (pro-Spc) cells. Labeling pattern similar in trachea 
but dramatically different in lung indicative of lineage restriction. E9.5 tracing: N=11 embryos from 3 litters, 
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all with extensive tdTom labeling in alveolar compartment; E10.5 tracing: N=7 embryos from 2 litters, all 
with minimal tdTom labeling in alveolar compartment. For TM exposure after E10.5: N>18 from at least 8 
litters, none with alveolar labeling. Scale bars: 10μm unless noted. 
 
 
Figure 10. Lineage restriction of extrapulmonary p63+ multipotent progenitors in the lung. 
(A-E) p63-CreERT2; R26-tdTomato lineage labeling: TM administration at E8.5 in vivo (A-D) or ex-vivo (E). 
IF of E9.5-E18.5 lungs: Nkx2.1+ tdTom+ cells in tracheal (Tr) and lung (Lu) primordia; at E15.5 tdTom+ cells 
are abundant in tracheal epithelium but extending ectopically to distal (Sox9+) lung buds (C, lower panel), 
by E18.5 tdTom+ are present in intrapulmonary airways (double-labeled with CC10) and alveolar sacs (D, 
double-labeled with pro-Spc). N=6 embryos from 3 litters showing extensive alveolar labeling with TM 
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exposure at E8.5. (E) Foregut explants from E8.5 reporter treated with 4-OHT and cultured for 5 days (left). 
IF: tdTom+ distal lung buds double labeled with Sox9 or Nkx2.1. Bud with ectopic distal tdTom labeling (box) 
enlarged in right panels. N=8 explants from two independent experiments. Scale bars: 10μm unless noted. 
 
To learn whether intrapulmonary airways were lineage-restricted at comparable early stages, lineage 
tracing of Sox9, which, similar to Id2, Spc and others, marks distal lung epithelial buds at E10.5 was 
performed40. Sox9-CreERT2; R26-tdTomato embryos were exposed to TM between E9.5-E11.5. Analysis 
of TM-treated at E11.5 embryos showed expected distribution of tdTom selectively in intrapulmonary 
(bronchioles) but not in tracheal epithelium. By contrast, TM at E9.5 resulted in tdTom extending ectopically 
to the tracheal epithelium (Figure 11A). Intriguingly, when lineage labeling was induced at E9.5, all the 
CGRP+ neuroendocrine cells in neuroendocrine bodies (NEBs) were tdTom+ (Figure 11C). However, in 
E11.5 tracing, not all the neuroendocrine cells in one NEB were labeled consistently, suggesting a multi-
clonal origin for NEBs (Figure 11B). Additionally, both distal progenitors and proximal progenitors may 




Figure 11. Lineage restriction of Sox9+ intrapulmonary multipotent progenitors in the lung. 
(A-C) Lineage analysis of Sox9-CreERT2; R26-tdTomato mice in vivo. IF: E18.5 trachea and lung 
(intrapulmonary airways) from embryos exposed to TM at E11.5 (A left panel & B) or E9.5 (A right panel & 
C).  Proper lineage restriction of distal Sox9 descendants to intrapulmonary airways confirmed by absence 
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of tdTom+ in tracheal epithelium (* p63+Sox2+) of TM-treated embryos at E11.5 but not at E9.5 (arrow: 
tdTom labeling extending to trachea). (B) Not all the neuroendocrine cells inside one NEB carried tdTom 
labeling with TM exposure at E11.5, suggesting a multi-clonal origin of NEBs. (C) TM exposure at E9.5 
extensively labeled neuroendocrine cells.  
 
3-6. Early specification of BC-containing epithelia 
TM exposure at E9.5 or E8.5 labeled airway epithelial cells in both proximal compartment and distal alveolar 
compartment. Interestingly, this lineage-tracing result could be consistently recapitulated when TM was 
administrated at E7.5 and as early as E6.5 (Figures 12A-C). The labeling pattern was not random. When 
gastrulating embryos at E6.5 were exposed to tamoxifen, only epidermis, a small subpopulation of neuronal 
cells, laryngeal epithelium, which are known to have p63+ cells in early developmental stages, bear the 
lineage label; in contrast, heart, liver, kidney and somite, which never have p63 expression, never got 
labeled (Figure 12A). Interestingly, lung epithelium showed lineage label in all embryos examined, 
suggesting a potential lung or foregut progenitors specified early in gastrulation stage. This was further 
confirmed in p63-CreERT2; Rosa26-lacZ lineage tracing. The foregut endoderm was extensively labeled 
at E8.5 when tamoxifen was administered at E6.5 (Figure 12D). When foreguts were dissected from E8.5 
embryos exposed to tamoxifen at E6.5 and cultured for another 3 days, similar labeling pattern in the 




Figure 12. Early labeling of lung epithelium with TM treatment before E8.5. 
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(A-C) Lineage labeling of p63-CreERT2; R26-tdTomato embryos with TM exposure at E6.5 and analyzed 
at E12.5. (A) IF of whole-embryo section showed extensive labeling in in laryngeal epithelium (i), skin (ii), 
subpopulation of neurons (iii), but never in heart (iv), liver (v), kidney (vi) or somites. (B) IF of lung section 
showed significant labeling in alveolar compartment as well as in the proximal airways. (C) Whole-mount 
immunofluorescence of E12.5 lung showing lineage-labeling in both Sox2+ proximal airways and Sox2- 
distal compartment. (D) Lineage labeling of p63-CreERT2; R26-lacZ embryos with TM exposure at E6.5 
and analyzed at E8.5. LacZ staining showed extensive labeling of p63 lineage in foregut endoderm. (E) 
p63-CreERT2; R26-tdTomato embryos were exposed to TM at E6.5, foreguts were then isolated at E8.5 
and cultured for 3 days. IF of foregut explants after 3 days in culture showing that the primordial lung buds 
were labeled by tdTomato. The lineage-labeling patterns in both cases were similar to the in vivo tracing 




Chapter 4. Dual roles of p63 in airway development 
 
4-1. p63 is required for the specification of airway BCs, but dispensable for luminal lineage 
balance 
The lineage tracing analyses suggested that embryonic p63+ progenitors made equal contributions to 
multiciliated versus secretory lineages in luminal compartment during embryonic development. Previous 
publications suggested that knockout of p63 gene resulted in a disrupted balance in luminal lineages, in 
which multiciliated cells increased significantly at the expense of secretory cells82,118. As the several p63-
deficient mice generated contradictory results, there has been no definitive conclusions for more than a 
decade66,68-70,77,78,119,120. To solve this issue, the p63-CreERT2 knock-in allele was used to generate a new 
homozygous deletion of p63 knockout model.  
This knockout (KO) model could be more suitable for correlations with the findings of the lineage analysis. 
The KO animals phenocopied the severe skin and limb defects previously reported68,77. The tracheal 
epithelium showed no p63+ Krt5+ cells (Figures 13A & B). Similar expression of CC10, Scgb3a2, and Foxj1 
in E18.5 wild-type (WT) and KO tracheas by immunofluorescence and qRT-PCR suggested that p63 did 
not influence secretory versus multiciliated fate specification (Figures 11A & B). This was in agreement with 
the comparable distribution of tdTom in secretory and multiciliated cells in lineage-tracing analysis (Figure 
8A). No difference in intrapulmonary airways including neuroendocrine lineage was observed (Figure 13D), 
confirming the minimal effect of p63 on intrapulmonary airway cell fates.  
In contrast to the requirement of p63 to maintain the proliferative potential of stem cells in skin and 
thymus71, the proliferative activity of airway epithelium was not affected in the p63CreERT2/CreERT2 
knockout animals (Figure 14A), consistent with the observation that p63+ cells did not exhibit higher 





Figure 13. p63 KO mutants have preserved luminal lineage balance with altered maturation and 
organization of the pseudostratified epithelium. 
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(A-E) Tracheal differentiation in E18.5 WT and p63 null (KO) mice. (A) IF, markers of basal (p63, Krt5), 
luminal (Krt8), secretory (CC10, SSEA1), multiciliated (Foxj1, A-tub), airway progenitor (Sox2) cells. Far 
right panel: maximum projection of confocal z-stack images showing colocalization of A-tub+ cilia and Foxj1+ 
nuclei; magenta arrows showing Foxj1+ multiciliated cells without cilia. (B) qRT-PCR, p63, Foxj1, CC10, 
Jag2 (Notch ligand), Scgb3a2 (secretory marker), (C) Morphometric analysis of A-tub and SSEA1. (D) 
E18.5 intrapulmonary airways of WT and p63 KO showing similar expression of Cgrp and Sgb3a2 
(neuroendocrine and secretory cell markers). (E) Alcian Blue and A-tub staining of E18.5 WT and KO 
tracheas: Brown arrows showing A-tub+ cilia; Cyan arrows showing Alcian Blue+ goblet cells. (F) IF showing 
simplified epithelial structure from the pseudostratified tracheal epithelium in the KOs at E18.5; graph: 
epithelial cell number per unit basement membrane length (mm). (G) p63-CreERT2 lineage tracing and IF 
showing Notch3+ tdTom+ in tracheal epithelium at E18.5 (TM administration at E13.5); insets: single 
channels depicted from boxed area. (H) IF E18.5 tracheal sections: Strong Notch3 nuclear staining in 
suprabasal cells of WT (nuclear Sox2 in all epithelial cells), however in p63 KO Notch3 was diffusely 
expressed at low levels in cytoplasm and no longer in the nucleus. Graphs: mean ± SEM from 6-12 fields 
per sample, N≥3. Statistics: Student’s t-test: *P<0.05; **P<0.01; ****P<0.0001; n.s. non-significant. Scale 
bars: 10μm. 
 
4-2. p63 is required to prevent advanced maturation in luminal progenitors 
Although no alteration in the balance of two major luminal lineages was observed in the p63 null animals, 
A-tub labeling was more abundant in KO epithelia at E18.5, suggesting that once committed, ciliated cells 
matured to a greater extent to form multicilia (Figures 13A and 13C). In E18.5WT animals, not all Foxj1+ 
ciliated cells had A-tub+ multicilia. Nevertheless, the Foxj1 A-tub double-positive multiciliated cells were 
overrepresented in the p63 KO trachea. This suggested that even though the specification of ciliated lineage 
was not affected, after cell fate selection, the maturation process of multiciliated cells was advanced in the 
p63 KO. This was actually consistent with the reported phenotype in Daniely et al., 200482, as they only 
used tub IV, a late marker for mature cilia detection, as the marker to evaluate abundance of multiciliated 
cells.  
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Moreover, expression of SSEA1, which marks immature secretory cells121, was greatly reduced in KO 
tracheas both at early (E15.5) and late (E18.5) stages, while unaffected in intrapulmonary airways 
(reflecting the regional distribution of p63+ cells in WT) (Figures 13A, 13C, 13D, 14B). By contrast, 
numerous Alcian blue-labeled cells in KO indicated that, without p63, secretory progenitors undergo 
aberrant goblet cell differentiation (Figure 13E). 
As expected from the absence of BCs, the pseudostratified architecture of the tracheal epithelium was 
converted into a columnar epithelium with a reduction in the epithelial cell number by 36.4% in KOs (Figure 
13F). Nuclear Notch3+ tdTom+ was present in E18.5 p63-CreERT2 tracheas (Figure 13G; Mori et al., 
2015122). However, in KO tracheas Notch3 was expressed diffusely and no longer in the nucleus, likely from 
the limited Jag ligand available for Notch3 activation without p63+ cells (Figure 13H). Indeed qRT-PCR 
showed decreased Jag2 expression (Figure 13B). Low Jag levels, presumably from multiciliated cells, could 
still induce expression but not activation of Notch3. Altered Notch3 could potentially influence differentiation 
behavior but not fate choice. Thus, the phenotype observed could be potentially explained by the loss of 
BC progenitors in the absence of p63, with an alternative progenitor (p63-independent) then undergoing an 
aberrant luminal differentiation program. This would suggest that prenatal p63 is crucial in generating not 
only the postnatal BC pool, but also the embryonic progenitors of luminal cells able to carry the normal 
differentiation of the developing airways. 
Laryngeal epithelium is continuously extended from tracheal epithelium, but these two epithelia exhibit 
important differences. In contrast to the pseudostratified architecture of tracheal epithelium, laryngeal 
epithelium is stratified, similar to esophagus and skin. Cells in laryngeal epithelium are negative for Nkx2-
1 but positive for Sox2, representing an endodermal lineage. Similar to other stratified epithelia like 
esophagus and skin, laryngeal epithelium is composed of a basal-cell layer with luminal cells on top. In p63 
KO animals, the E15.5 laryngeal epithelium exhibited a more advanced maturation compared to the 
tracheal epithelium. As expected, the stratified architecture was disrupted in the p63 null animals. 
Interestingly, many luminal cells in E15.5 WT laryngeal epithelium showed cytoplasmic immunostaining 
signal for A-tub, suggesting an intracellular organization prepared for the initiation of ciliogenesis. In E15.5 
KO animals, more ciliated cells with multicilia were identified (Figure 14C). Moreover, the SSEA1 
expression in luminal compartment was almost abolished in p63 KO laryngeal epithelium, reminiscent of 
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the E15.5 tracheal phenotype (Figure 14C). The difference in phenotype severity between trachea and 
larynx can be explained by different developmental mechanisms adopted in pseudostratified epithelium 
versus stratified one. In pseudostratified epithelium like trachea, the cells at early developmental stages 
(before E15.5) broadly express p63 at various and relatively low levels. Through some currently unknown 
signaling pathways (probably Notch due to lateral inhibition), some cells upregulate p63 and acquire BC 
fate, while others downregulate p63 and adopt luminal fate. This basal-luminal segregation was described 
above in the lineage-tracing analyses. In contrast, stratified epithelium like larynx initially starts with one 
single layer of p63-expressing BCs. These cells proliferate and give rise to luminal descendants on top 
during the switch from simple columnar epithelium to stratified architecture. So, it is possible that whether 




Figure 14. p63 KO animals exhibited advanced maturation phenotype as early as E15.5 before the 
appearance of characteristic BCs. 
(A) IF of E15.5 tracheas showing no difference in proliferation index (Ki67) in epithelium between WT and 
p63 KO mice. (B) IF at E15.5: marked reduction in SSEA1-expressing cells in KO selectively in trachea not 
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in intrapulmonary airways (lung; note Sox2 epithelial labeling in all panels but p63 restricted in WT). (C) IF 
of E15.5 larynx showing advanced ciliogenesis and marked reduced SSEA1 in p63 KO mice. Graphs in (A-





Chapter 5. Embryonic origin of bronchial progenitors responsible for H1N1-
induced Krt5+ pods 
 
5-1. Adult p63+ Krt5- bronchial progenitors generating Krt5+ pods after H1N1 challenge 
In adult murine airway system, p63+ Krt5+ BCs are restricted to trachea and extrapulmonary main stem 
bronchi. However, in extreme scenario that extensive damage is caused by H1N1 influenza virus in mouse 
lung, the ectopic Krt5+ p63+ basal-like cells emerge in intrapulmonary airways (airway Krt5+ cells) and 
cluster into “Krt5+ pods” in interstitial space (alveolar Krt5+ cells)101,102,105,106.  
To investigate the contribution from p63 lineage to the Krt5+ pods induced by H1N1 influenza infection, 
p63-CreERT2; R26-tdTomato adult mice were administered tamoxifen and infected with PR8 virus after 21 
days (Figure 15A). Analysis of these lungs showed massive expansion of the Krt5+ p63+ pods in the lung 
interstitium. These pods were nearly always colocalized with tdTomato labeling (Figures 15B-E). 
Quantification showed that more than 99.5% ± 0.5% and 98.9% ± 1.0% of airway and alveolar Krt5+ cells 
(N=5 from 3 independent experiments), respectively, were p63 lineage-labeled (Figure 15F). Notably, the 
Krt5+ pods were preferentially located in alveolar regions closely associated with main stem bronchi 
(Figures 16A-C; Zuo et al., 2015102). This suggested that the progenitors of Krt5+ pods could have originated 




Figure 15. p63 lineage-labeled cells generating the Krt5+ pods after H1N1 challenge. 
Lineage labeling of p63-CreERT2; R26-tdTomato mice infected with H1N1-PR8 21 days after TM 
administration in adulthood. (A-F) IF analysis of 15dpi lungs showing continuous trail of tdTom+ cells from 
large airway to alveolar space with nearly 99% tdTom+ labeling of the ectopic Krt5+ cells in the airway (C & 
D) and alveolar (C & E) compartments. Graph: mean ± SEM from 10-12 fields per sample. n=5 from 3 




Figure 16. H1N1-induced Krt5+ pods radiated outward from the bronchi. 
(A) Animals exposed to 5 doses of tamoxifen in adulthood and infected with H1N1 21 days after the last 
dose of tamoxifen to ensure no residual effect. (B) Tile scan IF of 15dpi lung section showing that lineage-
labeled Krt5+ pods were closely adjacent to lineage-labeled mainstem bronchi. (C) IF of 15dpi lung section 
showing that lineage-labeled cells invading interstitial space from proximal airways. Scale bars: 50μm. 
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5-2. Time course analysis of H1N1 injury response 
To closely examine the cellular origin of these Krt5+ pods and their potential migrating trail, a sequential 
analysis of their behavior was conducted during H1N1-induced injury. At 0dpi, several p63+ Krt5- cells 
bearing lineage-label were seen at the boundary between intrapulmonary and extrapulmonary main stem 
bronchi (Figures 17A-D). At 8dpi these cells expanded toward adjacent regions in lobar bronchi (Figures 
17E-G). At 11dpi, a few Krt5+ cells started to appear in the p63+ lineage-labeled epithelium in proximal 
airways. Moreover, in areas of more severe injury, small pod-like Krt5+ p63+ tdTom+ structures were first 
observed (Figures 17H-K). Notably the most distally located lineage-labeled p63+ cells assumed the basal 
location, suggestive of a migratory behavior (Figure 17I-K). A trail of p63-lineage-labeled cells was more 
apparent at 15dpi and in association with adjacent interstitial Krt5+ pods (Figures 16B-C, 17L). Consistent 
with previous reports (Vaughan et al. 2015), these Krt5+ pods failed to resolve and persisted as Krt5-
expressing cysts at 58dpi (Figure 17L). The stepwise acquisition of Krt5 and their noticeable trail from large 
airways (where we identified p63+ Krt5- tdTom+ cells in uninfected lungs) to areas undergoing remodeling, 
support their short-range migratory behavior and the idea that progenitors for these lesions reside in the 





Figure 17. Time course study indicated that the p63 lineage-labeled resident p63+ Krt5- progenitors 
in main bronchi migrated along proximal airways towards the area with most severe damage to 
generate Krt5+ pods after H1N1 challenge. 
(A, E, H) Tile scan of lung IF showing the proximal-to-distal progression of p63 lineage-labeled cells in main 
stem bronchi at 0dpi, 8dpi and 11dpi. (B-D) tdTom-labeled p63+ Krt5- cells showed in high magnification 
residing in main stem bronchi near lung boundary at 0dpi. (F, G, I, J, K) More tdTom-labeled p63+ Krt5- 
cells can be identified at basal location of intrapulmonary airways at 8dpi (F, G) and at 11dpi (I, J, K). (L) 
Extensive tdTom labeling of the airway epithelium with migrating trail towards adjacent alveolar space to 
form the p63+ Krt5+ tdTom+ clusters and honeycomb-like structures (15dpi) which persisted by 58dpi. Scale 
bars: 10μm unless noted. 
 
In PBS-mock infection, no lineage-labeled trails have been identified along intrapulmonary main stem 
bronchi (Figure 18A). Krt5- p63+ bronchial progenitors could be identified in the intrapulmonary main stem 
bronchi, but these cells did not expand without injury. To evaluate the effect from TM-independent 
recombination events, p63-CreERT2; R26-tdTomato mice without exposure to TM were infected with H1N1 
and examined at 15dpi. Although rare tdTom+ cells could be identified in the H1N1-induced Krt5+ pods at 
15dpi, the lineage labeling contribution was minimal (Figure 18B). Therefore, the p63+ Krt5- bronchial 
progenitors residing in the most proximal part of large intrapulmonary airways are the only cellular source 




Figure 18. Generation of Krt5+ pods depended on H1N1 challenge, and TM-independent 
recombination events contributed minimally to the lineage labeling. 
(A) PBS mock-infection showing the rare lineage-labeled p63+ Krt5- intrapulmonary progenitors (arrow) 
unaltered after 22 days. (B) IF analysis of 15dpi lung sections from p63-CreERT2; R26-tdTomato mice 
without TM exposure showing minimal tdTom labeling in the H1N1-induced Krt5+ pods. Scale bars: 10μm 
unless noted. 
 
5-3. Persistence of injury-induced Krt5+ pods 
The ectopic appearance of p63+ Krt5+ basal-like cells in interstitial lung after H1N1 injury is intriguing and 
has motivated extensive debate whether these cells are adult stem cells responsible for alveolar 
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regeneration101,102,105-107. To solve this controversy, the lineage commitment of H1N1-induced Krt5+ pods 
was examined for an extended time after virus exposure. p63-CreERT2; R26-tdTomato system with TM 
administration in adulthood and analyzed at 58dpi showed lineage labeling in almost 100% of the Krt5+ 
pods (Figure 19A). Consistent with Ray, et al., 2016106, Vaughan, et al., 2015105, Xi, et al., 2017107, the 
lineage-labeled cells were found to persist as cysts in the damaged lung regions, reminiscent of the Krt5+ 
pathological scars in IPF (Figure 19B; Vaughan, et al., 2015105). Comparing to the Krt5+ pods at 15dpi, the 
cysts were dilated with bigger lumen and Krt5+ cells seemed to switch from the squamous morphology to a 
relatively flattened cellular structure at 58dpi (Figure 19B). A considerable amount of lineage-labeled cells 
no longer expressed Krt5 or p63, and mucus could be observed in the lumen, suggesting a putative 
bronchiolization process. Lineage-labeled cells did express Pdpn, a marker for AT1 cells (Figure 19C). 
However, Pdpn is also expressed in airway BCs, rendering the conclusion that Krt5+ pods could resolve 
into alveolar lineages unsupported. Almost no pro-Spc+ tdTom+ cells were observed (Figure 19C), 
suggesting limited contribution to AT2 lineage. In extremely rare cases, tdTom+ cells co-expressing Pdpn 
and pro-Spc could be identified, which might represent some limited cellular plasticity of these basal-like 




Figure 19. H1N1-induced Krt5+ pods persist with minimal regenerating activity at 58dpi. 
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(A) Animals exposed to 5 doses of tamoxifen in adulthood, infected with H1N1-PR8 influenza virus and 
analyzed at 58dpi. (B) IF of lung section showing lineage-labeled Krt5+ p63+ pods persisted in 
honeycombing structure. (C) IF analysis of 58dpi lungs showing persisted Pdpn+ tdTom+ cysts with minimal 
contribution to alveolar regeneration. *no fluorescent signal. Scale bars: 50μm unless noted. 
 
The lineage-tracing analyses showed that before E10.5, p63+ progenitors are multipotent to generate 
both airway and alveolar lineages, but this potential was lost by E10.5. The results in the H1N1 injured adult 
lungs showed that not even in the presence of catastrophic damage, the potential to generate alveolar fates 
is negligible. It is possible that epigenetic modification at E10.5 permanently restricted the plasticity of p63+ 
cells. Future investigations will be of great scientific significance to identify the molecular mechanisms for 
this fate restriction and to steer the regenerative potentials towards alveolar repair. 
 
5-4. Embryonic p63+ progenitors as the developmental origin of Krt5+ pod precursors 
The lineage-tracing analyses described here showed that a subpopulation of p63+ progenitors at E13.5 was 
maintained undifferentiated and established the basal stem cell pool of the adult trachea. To investigate 
whether this was also true in intrapulmonary airways, E14.5 lung sections were closely examined, revealing 
scattered p63+ cells in the intrapulmonary main stem bronchi with Krt8 expression (Figure 20A). The 
immunostaining signal of p63 in these intrapulmonary population was remarkably weaker than those in 
extrapulmonary airways (bona fide airway BCs). To follow the fate of these embryonic intrapulmonary p63+ 
progenitors, the same lineage tracing regimen was used with TM administration at E13.5. By E18.5, most 
of the tdTom+ cells were co-labeled with multiciliated cell marker Foxj1 or secretory cell marker CC10, or 
neuroendocrine marker CGRP (Figure 20B), suggesting that they contribute to the pool of differentiated 
epithelial cells during airway development. Again, consistent with previous analysis, no pro-Spc+ AT2 cells 
were labeled in this E13.5 tracing. Although not all intrapulmonary p63+ cells got labeled at E14.5 (Figure 
21A), tdTom+ p63+ Krt5- cells were present in E18.5 lungs (Figure 21B), suggesting that a subpopulation of 
these cells remained uncommitted by late gestation stage. Interestingly, these cells never acquired Krt5 




Figure 20. Embryonic intrapulmonary p63+ cells could differentiate into all luminal lineages in 
proximal airways. 
(A) IF of E14.5 lung section showing scattered p63+ cells in intrapulmonary main bronchi. (B) IF tdTom 
double-labeled with markers of airway/alveolar differentiation. Scale bars: 50μm.  
 
Morphometric analyses showed that recombination efficiency in intrapulmonary p63+ cells in this E13.5 
tracing was 6.7% ± 1.4%, markedly lower than the 35.7% ± 4.5% in tracheal p63+ cells (Figure 21D). This 
reflected the major difference in p63 promoter activities in these regionally distinct p63+ populations. 
Interestingly, with such low labeling efficiency and the fact that more than 96% of these lineage-labeled 
cells committed to luminal differentiation by E18.5, 53.9% ± 0.9% of the intrapulmonary p63+ Krt5- cells 




Figure 21. Embryonic intrapulmonary p63+ progenitors are maintained immature throughout 
adulthood. 
(A-C) Lineage tracing of p63+ descendants in intrapulmonary airways at E14.5, E18.5 and adult lung: TM 
in E13.5 p63-CreERT2; R26-tdTomato mice. IF tdTom double-labeled with p63 (A-C). (D) Top graph: % 
tdTom+ p63+ Krt5- cells in total intrapulmonary p63+ Krt5- cells; bottom graph: % tdTom+ p63+ cells in total 
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intrapulmonary tdTom+ cells. Graphs: mean ± SEM, N≥3 except E18.5 in E13.5 tracing (N=2). Scale bars: 
50μm. 
 
Then, the participation of these intrapulmonary p63+ Krt5- tdTom+ progenitors labeled prenatally was 
investigated in the adult lung response to injury. The basal-like morphology and p63 lineage suggested 
their involvement in the reported H1N1-induced aberrant alveolar remodeling107. p63-CreERT2; R26-
tdTomato embryos exposed to TM at E13.5 were infected in adulthood and examined after 15 days (15dpi). 
p63+ Krt5+ tdTom+ cells were found extensively in intrapulmonary airways (50.4% ± 28.3% labeling 
frequency) and alveoli (36.7% ± 17.6% labeling frequency) as clusters (pods) or honeycomb-like lesions 
(Figure 22A). By quantification, 36.7% ± 17.6% of airway Krt5+ cells were found to carry the tdTom label, 
and 50.4% ± 28.3% of alveolar Krt5+ cells were labeled, consistent with the ~50% labeling efficiency of 
bronchial p63+ Krt5- progenitors prior to injury (Figure 22B). This lineage tracing result, combined with the 
adult tracing analysis, indicated that the bronchial p63+ Krt5- progenitor pool responsible for H1N1-induced 
alveolar remodeling was established at E13.5, solely by the embryonic intrapulmonary p63+ cells with no 




Figure 22. Intrapulmonary progenitors derived from E13.5 p63+ cells mediate the H1N1 aberrant 
alveolar remodeling. 
Adult lung from mice exposed to TM at E13.5 and infected with H1N1 at 8 weeks. (A) IF at 15dpi: p63+ 
tdTom+ Krt5+ cells in intrapulmonary bronchi (i) and as alveolar clusters (ii. pods); boxed areas magnified 
in right panels. (B) Graphs: % tdTom+ Krt5+ cells in the H1N1-induced ectopic Krt5+ cells in the mice with 
TM treatment at E13.5 (left) or without TM exposure (right). Graphs: mean ± SEM, N≥3. Scale bars: 50μm 
unless noted. 
 
5-5. A subpopulation of p63+ Krt5- bronchial progenitors carrying CC10 lineage label 
Previous evidence of H1N1 induction of Krt5+ pods in CC10 lineage-labeled cells was deemed artefactual 
due to residual TM activity103,105. To circumvent this issue, adult CC10-CreERT2; R26-tdTomato mice were 
exposed to H1N1 21 days after the last TM-gavage administration. Analysis of 15dpi lungs showed robust 
induction of Krt5+ pods nearly filled the whole lung (Figure 23A). In contrast to the previous reports105,106, 
extensive tdTom labeling was found in the Krt5+ pods. Intriguingly, more tdTom-labeled Krt5+ pods could 
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be seen in more distal regions, although still occupying mainly in the large intrapulmonary airways. 
Quantification showed that the tdTom+ Krt5+ cell clusters consisted of 30.3% ± 12.0% of the alveolar Krt5+ 
and 45.1% ± 11.8% of the airway Krt5+ cells (Figure 23B-C). Collectively, all expressed p63, indicating that 
CC10 lineage-labeled clusters were a subpopulation of the total H1N1-responding p63 lineage-derived cells. 
This suspected CC10 lineage-labeled p63+ cells responsible for Krt5+ pods after injury challenge were 
probably located more distally.  
It showed that CC10 lineage-labeled cells could regenerate the alveolar compartment after H1N1 
challenge104. To re-examine this issue, the contributions of p63-CreERT2 and CC10-CreERT2 lineage-
labeled cells to AT1 and AT2 cells at 15dpi were compared. As mentioned above, although Pdpn+ 
squamous cells could be identified with tdTom in p63-CreERT2 tracing, these cells were unlikely to be 
newly generated AT1 cells. Rarely, one pro-Spc+ tdTom+ Pdpn- AT2 cell (pointed by white arrow in Figure 
23E left bottom panel) and one pro-Spc+ tdTom+ Pdpn+ cell (pointed by magenta arrowhead in Figure 23E 
left bottom panel) were identified, probably transitioning from a Krt5+ pod cell to an AT2 cell. In contrast, in 
CC10-CreERT2 tracing, more Pdpn+ tdTom+ cells could be identified. These cells were probably AT1 cells 
as they had long and thin extension, with typical AT1 cellular morphology (pointed by white arrow in Figure 
23E right upper panel). Additionally, more pro-Spc+ Pdpn- AT2 cells could be found bearing the lineage 
label, suggesting a significant contribution from CC10 lineage to alveolar regeneration. Nevertheless, 
CC10-CreERT2 labeled a big proportion of endogenous AT2 cells (Figure 23E right bottom panel). A recent 
paper showed evidence that a Wnt responsive subpopulation of AT2 cells (Axin2+ alveolar epithelial 
progenitors) plays major role in generating the nascent AT2 and AT1 cells during H1N1 injury repair89. It 
cannot be distinguished whether the contribution from CC10 lineage to alveolar repair was from the airway 




Figure 23. Intrapulmonary p63+ Krt5- progenitors include a subpopulation of CC10 lineage-labeled 
cells responsible for H1N1 induction of pods. 
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(A) CC10-CreERT2 adult mice exposed to H1N1 after 21days of TM exposure. IF: lung sections at 15dpi 
with CC10 lineage-labeled airways and Krt5+ clusters overlapping partially with lineage-negative Krt5+ 
clusters (green). (B) IF: tdTom+ “trail” expanding to alveolar compartment. (C) Graphs: % tdTom+ Krt5+ cells 
in the H1N1 induced ectopic Krt5+ cells in the mice with TM treatment in adulthood (left) or without TM 
exposure (right). (D) p63-CreERT2 adult lung at 15dpi: IF: less pods compared to CC10-CreERT2 
suggestive of a more attenuated response to H1N1.  (E) IF analysis of 15 dpi lungs showing rare tdTom-
labeled alveolar Type I (Pdpn+ pro-Spc- with line structure, upper panels) and Type II cells (Pdpn- pro-Spc+, 
lower panels) in both p63-CreERT2 and CC10-CreERT2 mice. *no fluorescent signal. Magenta arrowhead 
showing the tdTom+ intermediate cell co-expressing Pdpn and pro-Spc. Scale bars: 50μm in (B), 10μm in 
(E) unless noted. 
 
The possibility was tested that CC10 lineage-labeled p63+ Krt5- cells were already present in the adult 
lung prior to H1N1 infection. Remarkably, IF of TM-treated uninjured adult CC10-CreERT2 mice revealed 
about 31.9% ± 4.3% of the p63+ Krt5- cells scattered in the main intrapulmonary bronchi labeled by tdTom 
(Figure 24A-B). As ~30% of bronchial p63+ Krt5- progenitors were labeled in CC10-CreERT2 mice prior to 
injury, and ~30% of ectopic Krt5+ cells carried the lineage label at 15dpi, it could be inferred that the CC10 
lineage-labeled subpopulation of intrapulmonary p63+ Krt5- progenitors were responsible for the lineage-




Figure 24. A subpopulation of intrapulmonary p63+ Krt5- progenitors could be labeled by CC10-
CreERT2 lineage. 
(A) Uninjured adult CC10-CreERT2 mice 21 days after Tm: rare CC10 lineage-labeled p63+ Krt5- 
progenitors in intrapulmonary main bronchi (i) near unlabeled p63+ Krt5- cells (ii). (B) Graph: % tdTom+ p63+ 
Krt5- cells in total intrapulmonary p63+ Krt5- cells.  Graph: mean ± SEM, N≥3. Scale bars: 50μm unless 
noted. 
 
Moreover, the labeling pattern of H1N1-exposed p63-CreERT2 and CC10-CreERT2 differed dramatically 
in the trachea. Each reporter labeled its respective cell type in TM-treated uninjured trachea (Figure 25A-
C). By contrast, after injury p63-CreERT2 mice labeled almost all the epithelial cells in both basal and 
luminal compartments but none in CC10-CreERT2 mice (Figure 25B-C). This confirmed the stem cell 
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identity of the adult tracheal p63+ Krt5+ tdTom+ in post-injury repair and further supported the idea that the 
progenitor cells sharing both CC10 and p63 lineages reside in intrapulmonary airways, not the trachea. 
 
 
Figure 25. Spatial restriction of CC10 lineage-labeled p63+ cells inside the lung. 
(A) Adult p63-CreERT2; R26-tdTomato or CC10-CreERT2; R26-tdTomato mice were exposed to TM by 
oral gavage and then subjected to H1N1 challenge 21 days after the last dose of TM administration. (B-C) 
Tracheal sections of adult p63-CreERT2 (left panel) or CC10-CreERT2 (right panel) mice showing no p63+ 
CC10 lineage-labeled cells in the uninjured tracheal epithelium (present in the uninjured intrapulmonary 
epithelium). Bottom panels: H1N1 injury results in extensive epithelial repair at 15dpi by p63 lineage-labeled 
but not CC10 lineage-labeled tdTom+ cells in trachea. Scale bars: 10μm.  
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The extensive labeling pattern in the H1N1-induced ectopic Krt5+ cells was not observed in other Cre 
lines (Spc, Upk3a, Notch3-driven) using the same TM regimen (Figures 26A-C), further suggesting the 




Figure 26. Variable Cre lines of lung lineages show minimal labeling in the H1N1-induced ectopic 
Krt5+ cells. 
(A-C) IF analysis of 15dpi lungs showing non-overlapped pattern between tdTom lineage label and Krt5 
cells. Left panel showing tile scanning images of whole lung sections; right panels showing areas of Krt5+ 
pods. (A) Spc-CreERT2 line labeling the descendants of alveolar Type II cells. N=2 from two independent 
experiments. (B) Upk3A-CreERT2 line labeling the descendants of secretory cells associated with 
neuroendocrine bodies and terminal bronchioles. N=5 from 3 independent experiments. (C) N3-CreERT2 
line labeling the descendants of mesenchymal and scattered epithelial cells in airways. N=3 from one 
experiment. Scale bars: 50μm unless noted. 
 
5-6. p63 haploinsufficiency in H1N1 injury response 
A comparison of H1N1-infected CC10-CreERT2 and p63-CreERT2 mice suggested a more attenuated 
response of the p63-CreERT2 knock-in mice with less pods (Figure 23A & D). Therefore, p63 
haploinsufficiency was hypothesized to influence this response. Notably, the H1N1-infected CC10 reporter 
mice showed Krt5+ pods at a significantly higher frequency (100%), some slightly less proximal compared 
to p63-CreERT2 mice at similar dpi. Moreover, in average 20 p63+ Krt5- cells per lung section could be 
identified from the adult CC10-CreERT2 mice during homeostasis, while this number decreased to 3 in 
p63-CreERT2 mice, suggesting an allelic function of p63 in generating or maintaining this progenitor pool 
in intrapulmonary airways.  
To avoid confounding factor from mouse background, the injury response between p63-CreERT2; R26-
tdTomato mice were compared with their p63+/+; R26-tdTomato littermates. Similar to the CC10-CreERT2 
mice which possessed two functional alleles of p63 gene, the p63+/+; R26-tdTomato littermates produced 
massive Krt5+ pods in the lung, while the p63-CreERT2; R26-tdTomato mice showed much fewer pods with 
more enrichment in the proximal part of lung (Figure 27A &C). This difference was also found in other 
CreERT2 knock-in lines tested in which disruption of the endogenous gene did not affect the progenitor 
pool (Figure 26A-C). About 60% of the p63 heterozygous mice failed to generate ectopic Krt5+ cells after 
injury, although their lung experienced similar levels of injury shown by collapse of alveolar structure and 
massive infiltration of immune cells (Figure 27B). In those p63-CreERT2 mice showing Krt5+ pods, all 
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ectopic Krt5+ cells were Sox2+ and Nkx2.1+, and these pods were closely associated with the regions of 
most severe alveolar damage as shown by the lack of Sox2+ or Nkx2.1+ lung epithelial cells (Figure 27A).  
 
 
Figure 27. Dramatically attenuated response to H1N1 challenge due to p63 haploinsufficiency. 
(A) IF analysis of 15dpi lung sections of p63-CreERT2 mice: cells in the pods are Sox2+ and Nkx2.1+, while 
the surrounding parenchyma devoid of pods is absent of lung epithelial cells. (B-C) IF analysis of 15dpi 
lung sections of p63-CreERT2 mice or the p63+/+ WT littermates. N=10 for p63+/+ animals showing ectopic 
Krt5+ cells in lung after H1N1 challenge in two independent experiments. Note some p63-CreERT2 mice 
failed to generate the ectopic Krt5+ cells in response to H1N1 challenge, while this phenomenon was never 
observed in p63+/+ WT animals. 
 
5-7. p63 lineage contribution to a new “variant” neuroendocrine cells 
A collaboration study with Dr. Xingbin Ai’s group revealed that pulmonary neuroendocrine cells are 
heterogeneous in expression of CGRP and Tubb3. Tubb3 is a neuron-specific tubulin beta class III marker. 
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The neuroendocrine cells, especially those in NEBs, in mouse lungs are CGRP+, while in trachea, extremely 
rare neuroendocrine cells could be identified near the submucosal glands, expressing Tubb3. Some of 
these Tubb3+ cells also expressed CGRP at low levels.  
Cell culture experiments suggested that airway BCs could generate neuroendocrine cells (CGRP+ 
Tubb3+ or CGRP- Tubb3+). To investigate whether airway BCs served as the progenitors of tracheal 
neuroendocrine cells in vivo, the lineage labeling pattern was analyzed in the p63-CreERT2; R26-tdTomato 
mice with TM exposure at E17.5. As described before, E17.5 tracing labeled specifically p63+ Krt5+ Krt8- 
preBC population at E18.5 with a high efficiency of 95.6% (Figure 3). By P21, extensive tdTomato-labeled 
CGRP+ Tubb3+ cells (marked by white arrow in Figure 28B) and CGRP- Tubb3+ cells (marked by asterisk 
in Figure 28B) could be identified. These suggested that the rare neuroendocrine cells in trachea were 
derived from preBCs at E18.5 and were maintained by airway BCs during homeostasis.  
 
 
Figure 28. Neuroendocrine cells in trachea were derived from E18.5 p63+ preBCs. 
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(A) p63-CreERT2; R26-tdTomato mice were exposed to TM at E17.5 and analyzed for lineage labeling at 
P21. (B) IF of tracheal sections showing tdTom-labeled CGRP+ Tubb3+ neuroendocrine cells (arrows) and 
CGRP- Tubb3+ neuroendocrine cells (asterisks).  
 
To investigate whether the intrapulmonary p63+ Krt5- progenitors contribute to the canonical 
neuroendocrine cells during homeostasis and injury response, p63-CreERT2; R26-tdTomato mice were 
exposed with TM, and the tdTomato labeling was analyzed at 0dpi (21 days after the last dose of TM to 
ensure TM clearance) and 15dpi (Figure 29A). Canonical neuroendocrine cells in intrapulmonary airways 
did not express Tubb3 either prior to or after injury challenge (Figure 29B-C). There was minimal evidence 
supporting the contribution from p63 lineage to neuroendocrine cells at either 0dpi or 15dpi (Figure 29B-C).  
E13.5 TM exposure showed again no tdTomato+ CGRP+ cells (Figures 29E-F), although massive 
labeling could be observed in the surrounding Krt5+ pods. Given the low recombination efficiency of 
intrapulmonary p63+ progenitors at the embryonic stage, and the rare frequency of pulmonary 
neuroendocrine cells, p63 lineage probably had minimal to none contribution to the canonical 
neuroendocrine lineage inside the lung.  
To investigate whether secretory lineage contributes to the canonical neuroendocrine cells, lineage 
tracing was performed using CC10-CreERT2; R26-tdTomato mice with TM administration in adulthood 
(Figure 29G). As discussed above, the labeling efficiency was high enough to label the variant secretory 
cells surrounding NEBs (they express much low levels of CC10 comparing to the canonical secretory cells) 
(Figure 29H). Again CGRP+ Tubb3- canonical neuroendocrine cells were not labeled in this system either 
prior to or after injury challenge (Figures 29H-I). Furthermore, in the time course analysis after injury 
challenge, co-expression of Krt5 and CGRP was never observed at all stages analyzed. A significant 
amount of ectopic Krt5+ cells lining the intrapulmonary airways proliferated actively before 15dpi, shown by 
Ki67 staining (Figures 30A-D). But only extremely rare Ki67+ CGRP+ cells could be identified. Therefore, 
neither p63 lineage nor CC10 lineage contributed to the canonical CGRP+ Tubb3- neuroendocrine 




Figure 29. p63 lineage and CC10 lineage could not label classic PNECs in mouse lung. 
 73 
(A, D, G) Lineage tracing strategies in adulthood or embryonic stage. (B, C, E, F, H, I) IF analysis of 15dpi 




Figure 30. Little proliferation of PNECs after H1N1 challenge. 
(A-D) IF analysis of WT mouse lungs harvested at different time points following H1N1 infection. Boxed 




Chapter 6. Molecular characterization of p63+ progenitors during development 
and homeostasis 
 
6-1. Transcriptome analysis of airway BCs during postnatal maturation process. 
The lineage tracing analysis performed in embryonic p63CreERT2; R26-tdTomato animals indicated that 
in trachea preBCs at E18.5 self-renew to generate the adult basal stem cell pool. These preBCs at E18.5, 
although sharing multiple markers with adult airway BCs like p63, Krt5, Itgb4 (CD104), gradually acquire 
additional BC markers (e.g. NGFR) during postnatal development. This suggests a maturation process from 
preBCs to adult BCs. In addition, E18.5 preBCs have a higher proliferative rate (8% at E18.5 vs. 2% in 
adulthood; Figures 7A & 36B) and contribute more rapidly to the luminal lineages (Figures 3 & 25B), to 
elongate the growing tracheal tube during postnatal development. Aiming at revealing the molecular 
mechanisms regulating this BC maturation process, transcriptome analysis was performed to generate the 
gene expression profiles of E18.5 preBCs and adult TrBCs. Comparison between the gene expression 
patterns of these two populations may shed light on how adult stem cells develop and become quiescent. 
To obtain pure cell populations for E18.5 preBCs, p63-CreERT2; R26-tdTomato mice were exposed to 
TM at gestation day 17.5 and embryonic tracheas were isolated one day later. Adult TrBCs were isolated 
with TM treatment in adulthood and a chase time of 3 days. Both BC populations were isolated and sorted 
using both tdTomato and surface markers (EpCAM+; Lin-; tdTomato+; CD104hi) (Figure 31A). Cytospin 
results of sorted populations showed more than 90% of cells as p63+, and more than 95% as Krt5+ 
(transcription factors such as p63 are sensitive for sample preparation while intermediate filaments such as 




Figure 31. Isolation of E18.5 preBCs and adult BCs from tracheal epithelium. 
(A) Gating strategy to sort Lin- EpCAM+ tdTom+ CD104hi populations. (B) IF analysis of sorted cells after 
cytospin showing high purity based on p63 and Krt5 expression. Scale bars: 50μm. 
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E18.5 preBCs exhibited a distinct gene expression profile from adult TrBCs. For both populations, more 
than 83% of the sequencing reads were pseudoaligned to the genome (Figure 32A). Principal component 
analysis (PCA) was performed on all 12 transcriptomes, and this clustered all E18.5 preBCs together in 
contrast to other adult TrBC samples (Figure 32B). 658 genes were significantly enriched in E18.5 preBCs 
(q<0.01; b>1.5), while 524 genes were selectively enriched in adult TrBCs (q<0.01; b<-1.5) (Figure 32C). 
Gene ontology analysis revealed E18.5 preBCs overrepresented gene sets involved in “Extracellular 
structure organization”, “Tissue development”, “Organ morphogenesis”, and so on, while adult TrBCs 
showed overrepresented gene sets involved in “Immune system process”, “Defense response”, “Response 
to external stimulus”. Notably, gene sets for “Regulation of cell differentiation” and “Regulation of cell 
proliferation” were highly enriched in E18.5 preBCs, consistent with their higher capacities of self-renewal 
and differentiation (Figure 32D). By contrast, adult TrBCs in homeostasis contained subpopulations of cells 
more quiescent or transitioning towards luminal commitment, expressing transcripts shared with secretory 
or multiciliated cells.  
Gene set overlapping analysis of KEGG pathways revealed that components of Hedgehog, WNT, TGFβ 
and insulin growth factor (IGF) signaling pathways were significantly enriched in E18.5 preBCs, while adult 
TrBCs were enriched in Jak/Stat pathway (Figures 32D, 32F). Shh and Gli2 showed considerable 
expression levels in E18.5 preBCs (Figure 32F). As a downstream target of both Shh and TGFβ pathways123, 
Gli2 was reported to promote cell proliferation and to inhibit apoptosis, and to play important roles in multiple 
squamous cell cancers including lung squamous cell carcinoma and skin basal cell carcinoma124,125. 
Interestingly, hypoxia has been suggested to induce the transcription of Gli2 through Hif1α126. Cells at 
prenatal stages are generally under hypoxic environment. This might underlie the intrinsic difference 
between E18.5 preBCs and adult TrBCs in proliferative activities. Additionally, several Wnt ligands (Wnt5b, 
Wnt11, Wnt10b, Wnt6) were over-represented in E18.5 preBCs. The expression of Axin2 and Lef1 
suggested activation of canonical Wnt signaling pathway in these embryonic cells. Insulin signaling pathway 
was also activated, consistent with the fact that preBCs are responsible for populating both basal and 
luminal compartments during postnatal growth. Multiple BMP/TGFβ antagonists, Chrd, Fstl1, Fst, were 
enriched in E18.5 preBCs, suggesting suppression of BMP/TGFβ in these cells. Inhibition of BMP and 
TGFβ in adult epithelial BC culture enhances self-renewing capacity and represses spontaneous 
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differentiation62, and BMP signaling constrains cellular proliferation in adult BCs in homeostasis127. Here 
the data suggested that embryonic preBCs may employ the same strategy to maintain the progenitor status. 
On the other hand, high activity of Jak/Stat signaling pathway in adult TrBCs reflect that these adult cells 
are more prone to commit to differentiation and less to self-renew55. Interestingly, Socs3, as a negative 
regulator for Jak/Stat pathway128, was enriched in E18.5 preBCs, consistent with the difference observed 
in the transcriptomes of TrBCs and their embryonic precursors.  
Examination of the most differentially expressed genes confirmed previous report that Ngfr is only 
expressed postnatally (Figure 32E). Ndufa4l2, a gene highly induced by HIF-1α129, is the most significantly 
enriched gene in E18.5 preBCs. This might reflect the major difference of the two cells in environment 
oxygen before and after birth. Transcription factors found in E18.5 preBCs included Sox11, Hif3a, Mycn, 
Foxa2. The ETS-related transcription factors, Etv4 and Etv5, described as squamous cell oncogenes130,131, 





Figure 32. Transcriptome profiles of E18.5 preBCs and adult TrBCs. 
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(A) Bar graph showing the pseudoaligned ratios of E18.5 preBCs and adult TrBCs in an RNA-seq 
quantification program, Kallisto. (B) Principal component analysis (PCA) showing distinct difference 
between E18.5 and adult samples. (C) Volcano plot showing differentially expressed genes in E18.5 
preBCs and adult TrBCs represented in black dots; genes significantly enriched in E18.5 preBCs were 
labeled with gene names in blue (-log10(q)>2; b>1.5); genes significantly enriched in adult TrBCs were 
labeled with gene names in red (-log10(q)>2; b<-1.5). (D) Enriched pathways in each population. 
Representative MSigDB gene sets (GO biological process & KEGG pathways) in E18.5 preBCs (blue) and 
adult TrBCs (red). (E) Top 50 genes ranked by significance showing dramatic difference in expression 
pattern in E18.5 preBCs and adult TrBCs. (F) Distinct expression pattern of genes in each representative 
KEGG pathways. (G) E18.5 preBC-specific and adult TrBC-specific transcription factors. (E-G) Relative 
expression levels of genes (row-wise Z-score of mean tpm). N=6 for each population. 
 
6-2. Transcriptome analysis of adult tracheal BCs and esophageal BCs in homeostasis 
p63+ Krt5+ BCs are adult stem cells responsible for homeostatic maintenance and injury repair in multiple 
epithelial systems. The stem cell features of self-renewal and differentiation can be hijacked during disease 
or injury-repair. To identify the intrinsic regulators of the programs of tissue-specific lineage commitment, 
transcriptome analysis of tracheal BCs and esophageal BCs was performed in adult mice in homeostasis. 
The focus on these two BC types was based on four reasons: 1. Although the integrity of both epithelia is 
maintained by BCs, the tracheal epithelium differs from the esophageal epithelium in turn-over rate, 
epithelial architecture and cellular composition of the luminal compartment. Tracheal BCs proliferate slower 
and generate secretory and multiciliated cells that populate the pseudostratified epithelium. In contrast, the 
esophageal BCs proliferate much faster, and give rise to a squamous multilayered stratified epithelium. 2. 
Trachea and esophagus share a common developmental origin from the anterior foregut endoderm, which 
undergoes dorsal-ventral patterning to specify the ventral trachea and dorsal esophagus. 3. Trachea and 
esophagus develop closely associated with each other, and are likely to have been exposed common 
signals, which might underlie a reciprocal cellular plasticity between these two BC populations. 4. A number 
of studies show that the respiratory epithelium can undergo metaplastic changes and convert into a 
squamous stratified epithelium.  
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Pure TrBCs and esoBCs were obtained using the same sorting strategy as described above based on 
Lin- EpCAM+ tdTomato+ CD104hi (Figure 33A) and confirmed by cytospin (Figure 33B). For both BC 
populations, more than 86% of the sequencing reads were pseudoaligned to the genome (Figure 34A). 
TrBCs and esoBCs, although sharing many canonical BC markers and adult stem cell features, exhibited 
significant differences in their transcriptomes, analyzed by PCA (Figure 34B). 1081 genes were selectively 
over-expressed in TrBCs (q<E-10; b>2), and 661 genes were highly expressed in esoBCs (q<E-10; b<-1) 
(Figure 34C). Gene ontology analysis showed that TrBCs over-represented gene sets included “Immune 
system process”, “Response to external stimulus”, “Defense response”. EsoBCs showed 
overrepresentation in genes related to “Epithelial development”, “Regulation of cell proliferation”, 
“Epidermis development”, “Ribosome biogenesis”. This was consistent with the known difference in turn-
over rates between tracheal and esophageal endoderm (Figure 34D). Gene set overlapping analysis of 
KEGG pathways revealed that components of Hedgehog signaling pathway, basal cell carcinoma (BCC), 
and pathways in cancer were significantly enriched in esoBCs, while TrBCs have a transcriptome enriched 
in genes annotated with activated MAPK signaling pathway (Figures 34D & F).  
The leucine-rich repeat-containing G-protein coupled receptors, Lgr5 and Lgr6, are the receptors for R-
spondins, which potentiates the WNT signaling. Intriguingly, Lgr6 is among the most differentially expressed 
genes enriched in TrBCs, even though multiple WNT signaling pathway components (Wnt3a, Wnt10a, 
Wnt16, Fzd10) were highly expressed in esoBCs but not TrBCs (Figures 34E & F). Both Lgr5 and Lgr6 
have been described as stem cell markers in several different epithelial systems such as intestine, 
epidermis, and sebaceous gland. In the respiratory system, the mesenchymal populations expressing Lgr5 
and Lgr6 have been reported to promote alveolar differentiation and airway differentiation, respectively, 
through mesenchymal-epithelial crosstalk132. However, the roles of Lgr5 and Lgr6 in epithelial compartment 
remained unexplored. In our transcriptome analysis, we found that Lgr5 was specifically expressed in E18.5 
tracheal preBCs, although at low levels. Neither adult TrBCs nor esoBCs expressed Lgr5, indicating a 
temporal expression pattern of Lgr5 in TrBCs. Lgr6 was absent from adult esoBCs, but found at high levels 
in tracheal E18.5 preBCs and adult TrBCs, suggesting a tissue-specific expression pattern (Figure 34E). 
Further characterization of Lgr5 and Lgr6 expressing epithelial populations may reveal the heterogeneity in 




Figure 33. Isolation of adult BCs from tracheal and esophageal epithelia. 
(A) Gating strategy to sort Lin- EpCAM+ tdTom+ CD104hi populations. (B) IF analysis of sorted cells after 





Figure 34. Transcriptome profiles of adult TrBCs and esoBCs. 
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(A) Bar graph showing the pseudoaligned ratios of adult TrBCs and esoBCs in an RNA-seq quantification 
program, Kallisto. (B) Principal component analysis (PCA) showing distinct difference between TrBC and 
esoBC samples. (C) Volcano plot showing differentially expressed genes in adult TrBCs and esoBCs. 
represented in black dots; genes significantly enriched in adult TrBCs were labeled with gene names in 
blue (-log10(q)>10; b>2); genes significantly enriched in adult esoBCs were labeled with gene names in red 
(-log10(q)>10; b<-1). (D) Enriched pathways in each population. Representative MSigDB gene sets (GO 
biological process & KEGG pathways) in adult TrBCs (blue) and adult esoBCs (red). (E) Top 50 genes 
ranked by significance showing dramatic difference in expression pattern in adult TrBCs and esoBCs. (F) 
Distinct expression pattern of genes in each representative KEGG pathways. (E-F) Relative expression 
levels of genes (row-wise Z-score of mean tpm). N=6 for each population. 
 
Transcription factors significantly enriched in TrBCs included Nkx2-1, Hey1, Gata6, Epas1, Nr2f2. The 
over-representation of Foxj1, Foxi1, Ascl1 could be ascribed to early commitment of some TrBCs to 
differentiation programs towards multiciliated, ionocyte, and neuroendocrine lineages, respectively (Figure 
35A). EsoBC-enriched transcription factors included Pitx1, Grhl3, Barx2, Gli1, Foxe1, Notch3, Ovol1, 
Zfp750, Notch1 (Figure 35B). The paired-like homeodomain transcription factor 1, Pitx1, was reported to 
play a pivotal role in promoting squamous carcinogenesis, cooperating with Sox2 and p63133. Foxe1, a 
downstream target of Shh pathway, was reported to be expressed in basal cell carcinoma134. Grhl3, Ovol1, 
Zfp750 were reported to be critical in epidermal development and squamous differentiation135-137. Notably, 
a number of activator protein-2 (AP2) transcription factors, TFAP2E, TFAP2C, TFAP2A, were specifically 
enriched in esoBCs but not in TrBCs. TFAP2C was suggested to function as an initiation factor, 
epigenetically inducing the surface ectoderm chromatin landscape in the early differentiation process of 
epidermis79. Furthermore, TFAP2C has been found to be overexpressed in squamous cell lung carcinoma, 
and to promote lung tumorigenesis and epithelial-mesenchymal transition138. Exploring the functional roles 
of these transcription factors may provide mechanistic insights into the regulatory networks governing 




Figure 35. Distinct transcription factors enriched in adult TrBCs and esoBCs. 
(A) Adult TrBC-specific transcription factors (-log10(q)>10; b>2). (B) Adult esoBC-specific transcription 
factors (-log10(q)>10; b<-1). 
 
6-3. TrBC heterogeneity revealed by single cell RNA-seq analysis 
Lineage tracing studies using Krt5-CreERT22 and p63-CreERT2 support the idea that Krt5+ p63+ BCs are 
adult stem cells responsible for homeostatic maintenance and repair of the tracheal epithelium139. ~20% of 
TrBCs express Krt14, and previous studies have shown that this population was unipotent in 
homeostasis6,140. Additionally, unipotent BCs co-expressing low levels of c-myb or N2ICD were suggested 
to be primed for multiciliated or secretory lineage commitment, even before the acquisition of early luminal 
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progenitor marker Krt854. A subsequent clonal lineage tracing study using Krt5-CreERT2 and single cell 
qRT-PCR proposed that TrBCs include two subpopulations: basal stem cells (BSCs) expressing relatively 
higher levels of Dlk2, Dll1, Lmo1 and Snai2, and basal luminal precursors (BLPs) expressing relatively 
higher levels of Krt8 which labels cells that were still uncommitted but not stem-like as BSCs4. Interestingly, 
this study found Krt14 was equally detected in BSC and BLP populations, refuting the idea that Krt14+ BCs 
was a unique subpopulation of BCs. However, single cell qRT-PCR could not provide a comprehensive 
gene expression analysis, and only 17 BCs were analyzed in this study.  
To investigate the heterogeneity of TrBCs during homeostasis, 4,209 TrBCs from adult p63-CreERT2; 
R26-tdTomato mice (sorting strategy shown in Figure 31A) were isolated and profiled using 10X Genomics 
Chromium scRNA-seq. In total, 428 million reads were achieved (101,750 mean reads per cell), and the 
median value of the unique molecular identifier (UMI, each representing one transcript) number per cell 
was 10,802. 2,956 median genes were detected per cell (Figure 36A). Based on the whole transcriptomes, 
we identified 9 distinct clusters in these 4,209 cell profiles (Figure 36B). Markers such as EpCAM, Nkx2-1, 
Krt5 and Trp63 were widely expressed in all 9 clusters, confirming the purity of sorted TrBCs (Figure 36C 
& Figure 37). 243 cells expressing low levels of p63 and Krt5 and high levels of Scgb1a1 and Muc5b were 
annotated as Secretory cluster. 139 cells were considered as Squamous cluster as they expressed Krt14 
and Krt13. 96 cells co-expressing EpCAM, Nkx2-1, Krt5, Trp63 and Vim (Vimentin) were annotated as EMT 
cluster (epithelial-mesenchymal transition). 90 cells partially overlapped with the Krt14+ population 
expressing cell cycle markers, Mki67, Nusap1, Aurkb, were identified as Proliferating cluster (2.14% of total 
TrBC population). 28 Foxj1+ multiciliated cells and one Ascl1+ neuroendocrine cell were also identified. 4 
cells were annotated as Immune-related cluster as they co-expressed EpCAM, Nkx2-1, Krt5, and some 
immune cell markers CD244 (Natural Killer Cell receptor 2B4), Irf8 (Interferon Regulatory Factor 8), CD74 
(HLA class II histocompatibility antigen gamma chain) and others. The majority of the cells were clustered 




Figure 36. Clustering of tracheal BCs by single-cell RNA sequencing. 
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(A) Quality control for the 10X Genomics scRNA-seq data. Distributions of the number of UMI per cells 
(left), the number of genes (middle), and the sequencing information (right). (B) t-distributed stochastic 
neighbor embedding (t-SNE) of 4,209 scRNA-seq profiles, colored by cluster assignment and annotated 
using known lineage-specific markers. (C) Post hoc cluster interpretation based on expression of known 
lineage-specific markers. t-SNE presentation of 4,209 cells, colored by expression (log2(TPM+1)) of each 
marker gene.  
 
 
Figure 37. Expression levels (log2(TPM+1)) of cluster-distinct genes (rows) in each epithelial cells 
(columns). 
 
By analyzing the expression pattern of cluster-specific genes, we found that many secretory genes, 
including Scgb1a1, Scgb3a2, Scgb3a1 Lyz2, Aldh1a1 were widely expressed in all clusters with slightly 
higher expression levels in the Secretory cluster. In contrast, Muc5b, Bpifb1, Pon1, Creb3l1 and Tff2 were 
considered as more specific secretory lineage markers or representing a more mature status for secretory 
lineage (Figure 37).  
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The scRNA-seq profiles suggested two major clusters Basal-1 and Basal-2, with almost 1:1 ratio in the 
TrBCs. To further understand about the nature of these two TrBC subpopulations, their transcriptomes were 
compared (Figure 38A). Gene set overlapping analysis revealed that Basal-1 cluster cells expressed genes 
associated with drug metabolism, glutathione metabolism and retinol metabolism, while Basal-2 cluster 
cells expressed genes associated with WNT, TGFB and Hedgehog signaling pathways, non-small cell lung 
cancer (NSCLC), basal cell carcinoma (BCC) (Figure 38B). Interestingly, Hedgehog pathway, NSCLC, BCC 
had been found associated with genes specifically expressed in esoBCs compared to TrBCs (Figures 34D 
& F). Cited2 (Cbp/p300 interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2), a 
transcriptional modulator, was more enriched in Basal-1 (Figures 38C&D). Cyp2b10 was more enriched in 
Basal-2, suggesting potentially a more differentiated subpopulation comparing to Basal-1. Tppp3 (tubulin 
polymerization-promoting protein family member 3), the most enriched gene in Basal-2, was reported to act 
as an oncogene in NSCLC141. Another Basal-2 enriched gene, Cav1, was also reported to be required for 
tumor cell survival and growth in NSCLC142 (Figure 38C). EsoBC-specific transcription factors, Barx2, Klf4, 
were preferentially expressed in Basal-2, suggesting that Basal-2 might represent a cellular status more 
similar to BCs in stratified squamous epithelium (Figures 38C &D). Intriguingly, Isl1 is expressed in the 
ventral mesenchymal and epithelial cells of anterior foregut during development143, while Srf is a key smooth 
muscle differentiation gene expressed in dorsal mesenchymal compartment of trachea during 
development144. The enrichment of Isl1 in Basal-1 and Srf in Basal-2 may give some hints on the potential 
distinct spatial locations of these two subpopulations in the dorsal-ventral axis (Figure 38D).  
The 1:1 ratio of Basal-1 and Basal-2 subpopulations identified in the scRNA-seq analysis was 
reminiscent of the BSCs and BLPs proposed in Watson et al., 2015125. To examine the correlation of Basal-
1/Basal-2 and BSC/BLP, the distinct markers identified in the previous study which could distinguish BSCs 
and BLPs were analyzed again here. Krt8 was shown to be more highly expressed in BLPs, while Dlk2, 
Dll1, Lmo1, Snai2 were more enriched in BSCs4. In the differential gene expression analysis between 
Basal-1 and Basal-2, Krt8 was more highly expressed in Basal-2 (p=5.18E-139; d=-1.73); Dlk2 was more 
enrich in Basal-1 (p=1.38E-13; d=0.92); Dll1 and Lmo1 was not differentially expressed (Dll1: p=0.78; d=-
0.03; Lmo1: p=0.25; d=0.13); Snai2 was slightly enriched in Basal-2 (p=0.001; d=-0.34). Due to limited 
markers presented in the previous paper, the similarity between Basal-1/Basal-2 and BSC/BLP could not 
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be confidently assessed. Nevertheless, as discussed above and following, the Basal-2 subpopulation might 
represent a more luminal committed BC cluster with higher potential for squamous differentiation, and may 






Figure 38. BC subtypes showing unique gene expression patterns. 
(A) Volcano plot showing differentially expressed genes in Basal-1 and Basal-2 clusters represented in 
black dots; genes significantly enriched in Basal-1 were labeled with gene names in red (-log10(q)>10; d>1); 
genes significantly enriched in adult Basal-2 were labeled with gene names in blue (-log10(q)>10; d<-1). (B) 
Enriched KEGG gene sets in each population in Basal-1 (blue) and Basal-2 (red). (C) Top 25 genes 
significantly enriched in Basal-1 and Basal-2 showing markedly difference in expression pattern in these 
two clusters. (D) Basal-1 and Basal-2 specific transcription factors. (C-D) Relative expression levels of 
genes (row-wise Z-score of mean log2(TPM+1)). 
 
The Squamous cluster was intriguing, as normal pseudostratified tracheal epithelium could potentially 
undergo metaplastic transformation into squamous epithelium in injury challenge or pathological conditions. 
To characterize this subpopulation, differential gene expression profiles were generated by comparing the 
Squamous cluster to all the other cells (Figure 39A). Genes significantly increased in the Squamous cluster 
were associated with epidermal development, keratinocyte differentiation, keratinization, while genes 
significantly decreased in this cluster was associated with different metabolic processes and cellular 
homeostasis (Figure 39B). Gene signature for this cluster was generated, shown by top 50 genes with most 
differentially expressed pattern (Figure 39C). A recent scRNA-seq study revealed a cell population with 
high Krt13/Krt4 expression and named as hillock cells. These cells were reported to form stratified 
squamous structure in contiguous groups13. By crossing the gene signature of the Squamous cluster in this 
analysis with the hillock cell signature, 15 out of 50 top differentially expressed genes in the hillock cells 
were found overlapping with the top 50 signature genes in our Squamous cluster. The possibility could not 
be ruled out that the basal subpopulation in the hillock cells might be the same as this Squamous cluster in 
the present study. Many secretory cell-related genes such as Lyz2, Cyp2a5, Aldh1a1, Scgb1a1 were 
overrepresented in the hillock cell-associated genes, which was the weakness of Montoro et al., 201813 
(“hillock” cells were defined as Krt13+ Krt4+ cells, containing both the minor subpopulation of Krt5+ BCs and 
the major subpopulation of Krt5- LCs). The transcription factors enriched in the Squamous cluster included 
Barx2, Klf4, and Pax9, all associated with esoBC features or squamous differentiation. From the heatmap, 
the expression levels of these three key genes were found to increase from Basal-1 to Basal-2 to Squamous 
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cluster. Trp63 was significantly decreased in the Squamous cluster, indicating a relatively more 
differentiated status towards luminal lineages. Tsc22d3 was the most significantly decreased transcription 
factor in the Squamous cluster (Figure 39D). Interestingly, this gene was more highly expressed in Basal-
1 compared to Basal-2 (Figure 38D), further suggesting a trend for the squamous differentiation potentials 
increasing from Basal-1 to Basal-2 to Squamous cluster.  
To our knowledge, the transcriptome analysis here provided the first comprehensive characterization of 
TrBC heterogeneity in homeostasis with high resolution at gene expression level. In the recent two scRNA-
seq studies, several BC markers were identified13,145. By assessing the expression pattern of these BC 
markers,  majority of them were found failed to distinguish the TrBC clusters in the present dataset: Hlf, 
Icam1, Notch1, Ngfr, Krt15, Krt5, F3, Aqp3 were widely distributed in all clusters; Epas1 was more enriched 
in Secretory cluster; Procr, Sfn were more highly expressed in Squamous cluster. The signatures for each 
TrBC clusters identified in the present study generated novel markers for future in situ validation. 
Furthermore, the gene set overlapping analyses of distinct clusters revealed a trend towards squamous 
differentiation potential in different TrBC clusters. Further functional characterization of these genes could 





Figure 39. Squamous cluster showing unique gene expression patterns comparing to the rest cells. 
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(A) Volcano plot showing differentially expressed genes in Squamous cluster and the rest cells represented 
in black dots; genes significantly enriched in Squamous cluster were labeled with gene names in red (-
log10(q)>10; b>2); genes significantly decreased in Squamous cluster were labeled with gene names in 
blue (-log10(q)>10; b<-2). (B) Enriched KEGG gene sets in genes significantly increased in the Squamous 
cluster (red) and significantly decreased in the Squamous cluster (blue). (C) Squamous cluster gene 
signature. Top 50 genes ranked by fold change significantly enriched in Squamous cluster comparing to 
the rest cells. (D) Squamous cluster specific transcription factors. (C-D) Relative expression levels of genes 
(row-wise Z-score of mean log2(TPM+1)). 
 
6-4. EsoBC heterogeneity revealed by single cell RNA-seq analysis 
The mouse esophagus is lined by a stratified squamous epithelium, comprised of EpCAM+ Sox2+ p63+ BCs, 
EpCAM- Sox2- suprabasal cells and a keratinized superficial layer. The esophageal epithelium is 
surrounded by a relatively homogenous stromal and muscle layer, leading to the hypothesis that esoBCs 
are homogenous and equipotential, similar to the interfollicular basal cells in epidermis146. Two subsequent 
studies suggested that esoBCs are heterogeneous. One study using in vitro organoid culture and FACS 
analysis proposed that in the esoBC population, Itga6/Itgb4high CD73+ cells represent a less differentiated 
non-quiescent stem cell subpopulation, while the majority serve as transit-amplifying cells. Itga6/Itgb4high 
CD73- cells are considered as early transit-amplifying cells, and Itga6/Itgb4low cells are late transit-
amplifying cells147. The second study, using lineage tracing, showed that Krt15+ progenitors are the long-
lived stem cell population responsible for homeostasis and injury repair148. However, none of these studies 
addressed the heterogeneity from an unbiased way using comprehensive gene expression analysis.  
To investigate esoBC heterogeneity, 10X Genomics Chromium scRNA-seq was performed in 4,383 
sorted esoBCs from adult mice under homeostatic conditions (sorting strategy in Figure 33A), generating 
343 million reads in total, 17,815 median UMI per cell, and 3,504 median genes per cell (Figure 40A). Based 
on the whole transcriptomes, 4 distinct clusters were identified for these 4,383 profiles (Figure 40B). 12 
cells were considered as contaminated Mesenchyme, as they lacked EpCAM, Sox2, Krt5, Trp63 but 
expressed Vim. All the rest expressed EpCAM, Sox2, Krt5 and p63, confirming the purity of sorted esoBCs. 
582 cells were annotated as Proliferating cluster as they expressed Mki67, Nusap1, Aurkb and other cycling 
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markers (Figures 40B-C, Figure 41). This Proliferating cluster constituted 13.2% of total esoBC population. 
3,082 cells were identified as Basal-1 cluster while the other 707 cells were annotated as Basal-2, to 
distinguish their relative differentiation status (Figure 40B-C). Tgfbi and Dlk2 were biased enriched in Basal-
1 cluster, while genes associated with more squamous differentiation status, Krt13, Grhl1, Krt6a, and others. 
were biased enriched in Basal-2 cluster (Figure 40C & Figure 41). Interestingly, Dlk2 was found to be more 
enriched in Basal-1 cluster in TrBC dataset. This led to a hypothesis that Dlk2 marked a relatively less 
differentiated, more stem-like BC subpopulation in both trachea and esophagus. Dlk2 functions as an 
inhibitory non-canonical ligand for Notch1 receptor. Notch1 was expressed in both TrBCs and esoBCs. This 
suggested that the Notch activity might be repressed autonomously in the TrBC Basal-1 cluster and the 
esoBC Basal-1 clusters through the expression of Dlk2, consistent with the observation that 
pharmacological Notch inhibition led to expansion of TrBCs3,122 and Notch1 activation was required for the 
differentiation of esoBCs towards squamous lineage149. 
Previous studies suggested that proliferative activity was equally possessed by different esoBC 
subpopulations, thus leading to the theory of equipotent population-level stem cell activity147. The scRNA-
seq data presented here revealed that at least from the gene expression level, the Proliferating cluster was 
remarkably distinct from other clusters (Figure 41).  
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Figure 40. Clustering of esophageal BCs by single-cell RNA sequencing. 
 98 
(A) Quality control for the 10X Genomics scRNA-seq data. Distributions of the number of UMI per cells 
(left), the number of genes (middle), and the sequencing information (right). (B) t-distributed stochastic 
neighbor embedding (t-SNE) of 4,383 scRNA-seq profiles, colored by cluster assignment and annotated 
using known lineage-specific markers. (C) Post hoc cluster interpretation based on expression of known 
lineage-specific markers. t-SNE presentation of 4,383 cells, colored by expression (log2(TPM+1)) of each 
marker gene.  
 
 
Figure 41. Expression levels (log2(TPM+1)) of cluster-distinct genes (rows) in each cells (columns). 
 
To assess the differences between Basal-1 and Basal-2 clusters, differential gene expression analysis 
was performed for these two clusters (Figure 42A). Consistent with the expectation that Basal-1 cluster 
represented a less differentiated cell status and Basal-2 cluster represented a more luminal committed 
differentiation status, the gene ontogeny analysis revealed that Basal-1 cluster-specific genes were more 
associated with hemidesmosome assembly, organ morphogenesis, regulation of cell proliferation, response 
to growth factor, while the Basal-2 cluster-specific genes were more overlapped with biological processes 
including lipid metabolic process, epidermis development, keratinocyte differentiation (Figure 42B). In 
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contrast to DeWard et al., 2014147, no biased expression pattern for CD73 was observed. Nevertheless, 
Krt15 was indeed more enriched in the Basal-1 cluster (p=2.15E-132; d=2.78), consistent with the previous 
report that Krt15+ subpopulation behaved  more as progenitor-like cells148. Interestingly, based on the 
current analysis, Krt14 (p=7.66E-205; d=4.77) compared to Krt15 was more reliable to distinguish Basal-1 
versus Basal-2 clusters. The top gene most enriched in Basal-1 cluster, Wfdc2 (WAP four-disulfide core 
domain 2), was highly expressed in all 9 clusters from TrBC dataset, and had been associated with immune 
defense response in respiratory system150. Overexpression of Wfdc2 in endometrial cancer cell lines led to 
enhanced cell proliferation and colony formation151. The functional significance of this highly biased 
expression of Wfdc2 in esoBC Basal-1 cluster required further investigation.  
The specific enrichment of Wnt10a (p=3.12E-204; d=4.72), Igfbp7 (p=2.18E-170; d=4.65), Tgfbi 
(p=3.16E-143; d=3.92) in the Basal-1 cluster underpinned the importance of WNT, IGF, TGFB signaling 
pathways in maintenance of the esoBC progenitor potential, awaiting functional validation in the future 
(Figure 42C). Krtdap was the top gene significantly enriched in the Basal-2 cluster (Figure 42C). 
Consistently, Krtdap was found to mark the early differentiating keratinocyte in mouse oral epithelium152. 
Grhl1, Grhl3, Notch3, Klf4 were significantly enriched in Basal-2 cluster, representing a more squamous 




Figure 42. BC subtypes showing unique gene expression patterns. 
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(A) Volcano plot showing differentially expressed genes in Basal-1 and Basal-2 clusters represented in 
black dots; genes significantly enriched in Basal-1 cluster were labeled with gene names in red (-log10(q)>25; 
d>1.5); genes significantly enriched in Basal-2 cluster were labeled with gene names in blue (-log10(q)>25; 
d<-2). (B) Enriched GO biological process in Basal-1 cluster (blue) and Basal-2 cluster (red). (C) Top 25 
genes significantly enriched in Basal-1 and Basal-2 clusters showing dramatic difference in expression 
pattern in these two clusters. (D) Basal-1 cluster and Basal-2 cluster specific transcription factors. (C-D) 
Relative expression levels of genes (row-wise Z-score of mean log2(TPM+1)). 
 
To further investigate the three distinct esoBC clusters, the esoBC scRNA-seq data was interrogated 
again using “virtual inference of protein activity by enriched regulon analysis” (VIPER), a robust and 
unbiased systems biology algorithm to assess protein activity from gene expression data113. Tissue-specific 
interactomes were built through the algorithm for the reconstruction of accurate cellular networks 
(ARACNe153) using the 4,383 esoBC scRNA-seq profiles. In general, ARACNe first identifies statistically 
significant regulations through mutual information (MI), and then eliminates indirect regulations through 
data processing inequality (DPI)112,153. ARACNe networks are then used in the VIPER algorithm as the 
basis for protein activity assessment. Conventional gene expression profile analysis uses the expression 
levels of each single gene. However, scRNA-sequencing technology suffers from inevitable technical 
noises, mainly by low sequencing depth and large gene dropout effects. More adversely, genes, especially 
transcription factors, which are expressed at relatively low levels, have a lower chance to be detected in 
general. In contrast, ARACNe-VIPER algorithms assess the protein activity of upstream regulators using 
the gene expression pattern of a battery of downstream targets, thus more resistant to the technical noises 
caused by gene dropout effects and more suitable to interrogate scRNA-seq datasets. Here, protein 
activities for each single cell were scored through VIPER, and the 4,383 esoBCs were presented in 
multidimensional scaling (MDS) plot based on the protein activities of VIPER inference. Consistent with the 
gene expression analysis, three discrete clusters could be identified here (Figure 43A).  
IterClust, an unsupervised statistic framework for iterative clustering analysis115, was then used to 
elucidate the heterogeneity of esoBCs in a hierarchical way. Round 1 separated C1-1 and C1-2 (Figure 
43B left panel), and Round 2 further separated the C1-1 in Round1 into 3 new subclusters (C2-1, C2-2, C2-
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3) and the C1-2 in Round 1 into 2 new subclusters (C2-4 and C2-5) (Figure 43B right panel). Based on post 
hoc annotation, C2-4 was found to represent proliferating cells, not only showing exclusive expression of 
multiple cycling markers such as Ccna2, Hmgb2, Cenpf, Cenpk, Rbl1, but exhibiting remarkably high 
protein activity scores (Figure 43C top panel and data not shown). The C2-5 represented bona fide basal 
progenitor cells. Even though the expression levels of p63, Sox4, Sox15, Pax9, Foxa1 did not significantly 
differ among these clusters, the protein activity was much higher in C2-5 and was negatively presented in 
C1-1, which further demonstrated that the protein activity analysis outcompeted gene expression analysis 
in this case. Another progenitor marker, Snai2, showed both enriched expression and higher protein activity 
in C2-5 (Figure 43C middle panel and data not shown). The C1-1 was considered as more luminal 
differentiated cellular status, as Notch3, Zfp750, Grhl1, Grhl3, Ovol1 were significantly more expressed in 
C1-1 and showed higher protein activities in C1-1 (Figure 43C bottom panel and data not shown). Another 
differentiation gene, Pycard, showed comparable expression levels in all clusters, but strong positive protein 
activity in C1-1 and negative protein activity in C2-4 and C2-5 (data not shown).  
This iterClust analysis suggested that the most pronounced differences in esoBC population was 
between the less differentiated cells (C2-5 and C2-4) and the more differentiated cells (C1-1). The 
difference between the progenitor cluster C2-5 (similar to the Basal-1 cluster in the expression analysis 
above) and the proliferating cluster C2-4 (similar to the Proliferating cluster in the expression analysis above) 
was subtler than the difference in lineage progression. Again, the esoBCs were found to consist of three 
major subpopulations, one in cycling status, one with more progenitor features, and one more committed 
towards luminal differentiation. The additional segregation of more differentiated C1-1 cells into 3 
subclusters in Round 2 (C2-1, C2-2, C2-3) might suggest three distinct lineage-primed differentiation 
programs in these cells, reminiscent of the lineage segregation theory in tracheal basal compartment 




Figure 43. Three subpopulations of esoBCs revealed based on protein activity profiles 
(A) Multidimensional scaling (MDS) visualization of 4,383 esoBCs based on protein activity analysis. (B) 
Iterative clustering analysis (iterClust) revealing three major clusters in esoBCs (C2-5, C2-4, C2-1+C2-
2+C2-3 from Round 2). (C) Post hoc cluster annotation by the expression and activity of known markers. 
MDS presentation of 4,383 scRNA-seq profiles (each dot), colored by the expression level (log2(TPM+1)) 
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of each marker gene in the expression plots, or the protein activity level (inferred through the ARACNe-
VIPER pipeline) of each marker protein in the activity plots. 
 
6-5. A subpopulation of TrBCs exhibiting esoBC-like features 
Trachea and esophagus share same developmental origin from the anterior foregut endoderm. The dorsal-
ventral patterning specifies ventral tracheal as Sox2+ Nkx2.1+ and dorsal esophagus as Sox2+ Nkx2.1-. BCs 
from trachea and esophagus share common BC markers such as Trp63, Krt5, and they both serve as adult 
stem cells for homeostatic maintenance and injury repair. However, these two BC populations have intrinsic 
differences in self-renewing activity and differentiation programs: TrBCs are relatively quiescent, with 
differentiation potentials towards luminal secretory (Scgb3a2, Scgb1a1) and multiciliated (Foxj1) lineages 
to maintain the pseudostratified epithelial architecture. In contrast, esoBCs are highly active in proliferation 
to fulfill the high turn-over rate of esophageal epithelium, and generate Krt4+ Krt13+ luminal descendants to 
maintain the stratified squamous epithelial architecture.  
In pathological conditions such as COPD (chronic obstructive pulmonary diseases), TrBCs may adopt 
an esophageal like differentiation program and generate squamous epithelium. The squamous metaplasia 
is reversible. Intriguingly, this pathological conversion can be recapitulated in air-liquid interface cultures. 
Under normal culture conditions, TrBCs generate pseudostratified epithelium with luminal secretory and 
multiciliated descendants, while esoBCs generate squamous stratified epithelium with Krt4+ Krt13+ 
suprabasal cells. However, upon withdrawal of retinoic acid, TrBCs can generate esophageal-like 
squamous stratified epithelium in vitro.  
The scRNA-seq analyses of TrBCs revealed that some subpopulations of TrBCs have features 
associated with squamous differentiation (Basal-2 & Squamous clusters in TrBC dataset, Figure 36B). To 
further characterize whether some TrBCs were more similar to esoBCs, the two scRNA-seq datasets of 
TrBCs and esoBCs were combined and analyzed together. Cells from the same tissue origin clustered 
together, as expected (Figure 44A left panel). General BC markers, Sox2, p63, Krt5 were distributed in both 
TrBC and esoBC populations. Nkx2-1 specifically marked TrBCs while Pitx1 specifically marked esoBCs 
(Figure 44A right panels).  
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5 clusters were identified using DBSCAN. C1 and C2 were from TrBCs; C3, C4 and C5 were from 
esoBCs (Figure 44B). To quantitatively assess the general features of these five clusters, GSEA was 
performed to evaluate the esophageal score and tracheal score. Specifically, the esophageal signature and 
tracheal signature (60-80 genes) were generated by differential gene expression analysis of bulk RNA-seq 
data of adult TrBCs and esoBCs (N=6 for each). Tracheal signature was defined as gene sets with 
log2(RPM+1)>5 and p<E-5; while esophageal signature was defined as gene sets with log2(RPM+1)>3 and 
p<E-3. Consistent with the hypothesis, C2, a subpopulation of TrBCs exhibited slightly higher esophageal 
score and slightly lower tracheal score comparing to C1, suggesting that C2 might represent a transitional 
cellular status between TrBCs and esoBCs (Figure 44C). Interestingly, the three esophageal clusters 
exhibited elevated esophageal scores from C5 to C4 to C3 (Figure 44C left panel). This might indicate that 
the esophageal score might be a good strategy to assess the differentiating status. Overall, a developing 




Figure 44. A subpopulation of TrBCs exhibiting esoBC-like features in transcriptome analysis. 
(A) t-SNE visualization of scRNA-seq profiles from both TrBCs and esoBCs, colored by cellular origin (left, 
TrBC in red, esoBC in black), or the expression level (log2(TPM+1)) of each marker gene. (B) 5 distinct 
clusters (2 in TrBCs, 3 in esoBCs) revealed by density-based spatial clustering of applications with noise 
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(DBSCAN). (C) The distribution of esophageal scores and tracheal scores (generated using the most 
differentially expressed genes from bulk RNA-seq analysis) for 5 clusters.  
 
To figure out which genes showed continuous dynamics along the observed trajectory, the expression 
patterns of different genes were characterized and their mean expression levels in each cluster were 
determined. Two transcription factors, Pitx1 and Barx2 were equally expressed at high levels in 3 esoBC 
clusters. C2 of TrBC exhibited higher expression of these two genes comparing to C1, suggested a gene 
regulatory level switch towards an esoBC-like status (Figure 45). Pitx1 (paired like homeodomain 1), was 
reported to function as regulator for squamous carcinogenesis. In tumor propagating cells, Pitx1 cooperates 
with Sox2 and p63 to promote self-renewal and to repress Klf4 expression to blunt squamous 
differentiation133. In esophagus and oral epithelium, Pitx1 was specifically expressed in BCs and its 
reduction had been associated with Barrett’s metaplasia, suggesting a functional importance of Pitx1 in 
regulating squamous differentiation in these epithelia154. Barx2 (BARX homeobox 2) was reported as a 
tumor suppressor gene through inhibiting WNT signaling pathway in NSCLC155. Barx2 was expressed in 
differentiating stratified epithelia from early development, including tongue, nasal epithelium, esophagus, 
skin156. The seemly antagonistic roles of Pitx1 and Barx2 in promoting self-renewal (Pitx1) or squamous 
differentiation (Barx2) might underlie a tumbledown transcriptional hub that was competent enough to 
commit differentiation programs of both TrBCs and esoBCs and was vulnerable to perturbation in 
metaplastic transformation. 
Tgfbi and Igfbp2 were highly expressed in three esoBC clusters and exhibited elevated levels in TrBC 
C2 comparing to C1 (Figure 45). In the bulk RNA-seq analysis for adult TrBCs and esoBCs, Tgfbi was 
highly expressed in esoBCs but not TrBCs, suggesting that the TGFB/BMP signaling pathway might play 
essential roles in defining the cellular identities of esoBCs (Figure 34E). Interestingly, TGFB is a major 
factor in driving squamous metaplasia of airway epithelial cells, and TGFBI ranked no. 10 among the top 
genes significantly induced during the in vitro human bronchial epithelial cells’ serial passage (which led to 
a gradual acquisition of a squamous cell phenotype)157. The IGF pathway is important in regulating cell 
growth, proliferation, metabolism. Although the detailed functions of Igfbp2 in BCs remained to be explored, 
it had been suggested in the diagnostic marker signature for esophageal squamous cell carcinoma 
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(ESCC)158. The potential activation of TGFB/BMP and IGF pathways in C2 might suggest that squamous 
metaplasia or malignant transformation may involve with further perturbation of these signaling pathways.  
Cytokeratins are intermediate filaments that could serve as markers for epithelial cells in different 
differentiation statuses or pathological conditions. Krt14 was widely expressed in esoBCs but restricted to 
a small population of TrBCs. C2 showed significantly higher expression of Krt14, suggesting that these cells 
differed from the C1 at least in squamous differentiation potential (Figure 45). Watson et al., 20154 reported 
that Krt14 was equally distributed in BSCs and BLPs, and was not a reliable marker of stem cell identity. 
This was not conflicted with the current observation, since the present data suggested that Krt14 might 
serve as a marker for cells with more similar features as esoBCs in squamous differentiation potential, not 
necessarily reflecting the self-renewal capacity. This hypothesis was further corroborated by the 
observation that squamous differentiation markers Krt13, Dmkn (Dermokine, important in epidermis 
terminal differentiation159), Lgals7 (galectin 7, specifically expressed in keratinocytes and found mainly in 
stratified squamous epithelium160) and others were consistently elevated from C1 to C2 in TrBCs, and from 
C5/C4 (less differentiated) to C3 (more differentiated) (Figure 45). 
 
 
Figure 45. Genes exhibiting increased expression trend along the eso-score trajectory. 
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t-SNE plot showed scRNA-seq profiles from both TrBCs and esoBCs colored by the expression level 
(log2(TPM+1)) of each representative gene on the left. Boxplot showed the distribution of the gene 
expression level (log2(TPM+1)). Transcription factors were colored in red.  
 
Many airway-specific genes (Nkx2-1, Epas1, Fos) exhibited reduced expression from C1 to C2, implying 
an attenuated respiratory cell identity in C2 (Figure 46). Genes related to airway-specific differentiation 
programs or pathological conditions such as asthma, including Bpifa1, Scgb3a2, Lypd, Sult1d1, Lbp, Aqp4, 
Sftpd, Slc15a2, Abi3bp, Fmo2/Fmo3, Camk2n1, all showed expression reduction from C1 to C2 and 
significantly low or no expression in three esoBC clusters. Krt18, paired with Krt8, is a marker for simple 
columnar epithelial cells. EsoBCs in the stratified epithelium did not express this marker. A slight decrease 
in Krt18 expression was observed in C2, suggesting a putative switch from the pseudostratified-specific 
differentiation program towards the stratified-specific program in these cells (Figure 46).  
Here, the scRNA-seq datasets of TrBCs and esoBCs were combined, revealing a subpopulation of 
TrBCs with esoBC-like features at least at the gene expression level. The gene expression analysis and 
the TrBC-esoBC cell identity trajectory revealed that a considerable number of genes, not only 
differentiation marker genes, signaling pathway components, but transcription factors as well, showed 
altered expression patterns in the esoBC-like TrBC subpopulation. This suggested that genome-wide 
rewired regulatory networks in these cells might endow them the squamous differentiation potential. This 
unstable transcriptional hub might be easily perturbed or hijacked in chronic injury or carcinogenesis, 
leading to squamous metaplasia or malignant transformation into squamous cell carcinoma. 
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Figure 46. Genes exhibiting decreased expression trend along the tr-score trajectory. 
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t-SNE plot showed scRNA-seq profiles from both TrBCs and esoBCs colored by the expression level 
(log2(TPM+1)) of each representative gene on the left. Boxplot showed the distribution of the gene 
expression level (log2(TPM+1)). Transcription factor genes were colored in red.  
 
6-6. Identification of master regulator candidates using metaVIPER analysis 
As discussed above, TrBCs and esoBCs represent two adult stem cell populations with mucociliary 
differentiation program in pseudostratified trachea or squamous differentiation program in stratified 
esophagus, respectively. They exhibit unexpected cellular plasticity, and could adopt each other’s 
differentiation programs in vitro with retinoid acid manipulation or in disease scenarios. The cellular status 
is represented by a set of genes fulfilling distinct physiological functions, including controlling cell 
morphology, metabolism, proliferation, differentiation and so on. As gene products interact with each other 
to form a complex regulatory network (interactome), a handful of transcription factors located at the top of 
the gene regulatory hierarchy are considered as master regulators for the specific cell status. Perturbation 
of these few master regulators can collapse the original cellular homeostasis and drive differentiation into 
another phenotype. This concept has been confirmed in many reprogramming strategies: fibroblasts can 
be reprogrammed into pluripotent stem cells using Oct4, Sox2, Klf4 and c-Myc161; Ascl1, Brn2 and Myt1l 
can reprogram fibroblasts into functional neurons162; overexpression of one single transcription factor Ptf1a 
can endow a neural stem cell fate in fibroblasts163; Pdx1, Ngn3 and MafA can promote the 
transdifferentiation of pancreatic exocrine cells and liver cells into insulin-secreting pancreatic β cell fate164-
166.  
Classic studies used forward genetic screening to identify master regulators controlling cell phenotypes. 
a handful of transcription factors were selected in the candidate pool based on knowledge and prediction; 
then a systematic withdrawal or binary search was performed to identify the essential combination of master 
regulators. This forward strategy relied on previous knowledge and personal understanding, which 
inevitably introduced human bias. And the determination of final essential master regulator combination 
was laborious and costly. Recent advances in high-throughput technologies and systems biology solved 
these problems using a reverse genetic/engineering strategy to predict master regulators from gene 
expression profiles with high accuracy and specificity. The regulating logic can be reconstructed using 
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ARACNe algorithm112. Based on the ARACNe networks, the expression patterns of transcriptional targets 
were used as reporters for the protein activities of upstream transcriptional regulators. Transcriptional 
regulators with higher protein activity scores were considered as candidate master regulators responsible 
for the gene regulatory network of a specific cellular status113,167. Several studies confirmed its robustness 
and accuracy in inferring master regulators in cancer and tissue development168-170.  
Here, aiming at discovering master regulator candidates which control TrBC and esoBC statuses and 
perturbation of which leading to cell fate switch, TrBC and esoBC interactomes were built separately using 
their scRNA-seq datasets. Then these two interactomes were interrogated with bulk RNA-seq 
transcriptomes of TrBCs and esoBCs through metaVIPER algorithm114. At both gene expression level and 
protein activity level, TrBCs significantly differed from esoBCs (Figure 47A). Through metaVIPER, a list of 
proteins was identified showing significantly differential activities in either TrBCs (colored in red in Figure 
47B) or esoBCs (colored in blue in Figure 47B). As expected, probably due to post-translational regulation, 
the expression patterns of these candidate genes were not always consistent with their predicted protein 
activities (Figures 47C & D).  
The majority of the candidate master regulators in this list was previously not studied in airway or 
esophagus. Some genes, such as Fos, Cebpb, Pbxip1, had been identified as COPD-responsive gene and 
associated with squamous lung cancer171-175. Additionally, some genes showing higher protein activities in 
esoBC status had been suggested to relate with squamous transformation and keratinocyte differentiation. 
Ybx1 regulates the progenitor functions of epidermal stem cell and is associated with NSCLC176,177. Pitx1 
plays essential roles in skin squamous cell carcinoma133. High expression of Kat2a was found associated 
with ESCC risk178. Id1 has been suggested to promote tumor growth and progression in oral squamous cell 
carcinoma and NSCLC179,180. Interestingly, a lot of epigenetic modifiers (Kat2a, Yy1, Mbd3, Mybbp1a, Phf1) 
were presented in this list, suggesting a physiological importance of epigenetic regulation in controlling the 
cellular statuses between TrBCs and esoBCs.  
Alternative analysis could be performed as following: instead of building two ARACNe interactomes 
separately for TrBCs and esoBCs, these two scRNA-seq datasets could be combined and used for one 
single interactome construction. In this case, more than 8000 scRNA-seq profiles could be used to assess 
the regulatory logic for general BC status, which will significantly increase the accuracy. Then, the bulk 
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RNA-seq datasets for both esoBCs and TrBCs could be analyzed through VIPER algorithm, as the esoBCs 
and TrBCs are probably similar in general epigenetics. It would be interesting to compare the master 
regulator candidate lists generated from two separated interactomes with meta-VIPER to one combined 
interactome with VIPER. 
Future validation for these candidate master regulators is required. The in vitro differentiation assay using 
air-liquid interface culture and retinoic acid-deficient squamous metaplasia model might represent a suitable 
platform to test the phenotypic alteration following genetic manipulation. This functional test is phenotype-
driven, and highly depends on the reliability of the disease model. Another way to assess the functional 
importance of candidate master regulators is to use transcriptome as readout instead of phenotype, which 
should be unbiased but suffers from indirect correlation with final phenotypic outcome. High-throughput 
methods such as Perturb-seq or CROP-seq181,182, combining CRISPR-based gene expression perturbation 
and scRNA-seq, can be used to evaluate the importance of candidate master regulators in controlling gene 
regulatory networks. A combination of both assays will facilitate the functional validation of the candidate 
pool and provide mechanistic views to explain cell fate regulation from distinct angles. 
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Figure 47. Candidate master regulators inferred by metaVIPER analysis. 
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(A) Principal component analysis (PCA) showing distinct difference between bulk RNA-seq profiles (left 
panel) and protein activity profiles (right panel) of adult TrBCs (black) and esoBCs (blue). (B) Volcano plot 
showing distinct protein activities in TrBCs and esoBCs. Differential protein activity scores for all genes 
were represented in black dots; genes showing significantly higher protein activities in TrBCs were labeled 
with gene names in red (p<0.05; d>0); genes showing significantly higher protein activities in esoBCs were 
labeled with gene names in blue (p<0.05; d<0). (C) Relative expression levels of genes (row-wise Z-score 
of gene expression) inferred as candidate master regulators based on significantly distinct protein activities 
in TrBCs and esoBCs. (D) Table showing candidate master regulators with differential protein activity 
scores (d) and corresponding t-test p values (p).  
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Chapter 7. Conclusion 
 This thesis shows that when airways are still forming, two lineage-restriction events occur in p63-
expressing cells, which ultimately establish regionally distinct adult multipotent progenitor pools: the BCs in 
trachea and the p63+ Krt5- cells in intrapulmonary airways (Figure 48). 
In this study, an early onset of p63 expression was identified during specification of the lung field in 
anterior foregut endoderm since E9.0. Unexpectedly, these early p63+ cells are multipotent to generate all 
cell types of both airways and alveoli. At this time, the proximal p63 lineage has not been separated from 
the distal Sox9/Id2 lineage. From E10.5, a first proximal-distal lineage segregation event occurs. p63+ cells 
permanently lose the potential for alveolar differentiation, and become restricted to extrapulmonary airways. 
Sox9+ Id2+ distal epithelial progenitors mainly contribute to form the cell types populating intrapulmonary 
airways and alveolar compartment. A second basal-luminal lineage segregation event occurs at E13.5 in 
the trachea. Some of the p63+ cells labeled in the p63-CreERT2 lineage tracing system (potentially with 
higher p63 promoter activity) acquire BC fate and self-renew to expand the BC pool, while others commit 
to luminal differentiation directly.  
A population of embryonic p63+ cells is maintained immature and uncommitted in intrapulmonary large 
airways throughout lifetime. In adulthood upon H1N1 challenge, these p63+ Krt5- cells are recruited support 
the injured lung. They expand and migrate along the proximal airways towards the area of severe alveolar 
damage to form the Krt5+ pods. The specification/maintenance of intrapulmonary p63+ Krt5- progenitor pool 
depends on p63 gene dosage. Loss of one functional allele of p63 gene leads to a less effective response 
of this progenitor pool and ultimately a more attenuated response. The present study shows minimal if any 
alveolar regeneration from the ectopic Krt5+ pods, further suggesting that the alveolar differentiation 
potential of early multipotent p63+ progenitors is lost as early as E10.5, during the first lineage-segregation 
event. It is of great scientific interests and clinical value to investigate how this lineage restriction occurs 




Figure 48. Schematic presentation showing the contribution of p63 lineage during airway 
development and injury response. 
 
In the last part of this thesis, molecular signatures are generated for E18.5 preBCs in trachea, adult 
TrBCs and esoBCs. This reveals several signaling pathways which might play essential roles in TrBC 
maturation or the fate maintenance of adult TrBCs/esoBCs. The scRNA-seq datasets generated here 
uncover underappreciated heterogeneity in adult stem cell populations in trachea and esophagus. TrBCs 
contain clusters of cells with different levels of squamous differentiation potential, which may underlie the 
significant plasticity exhibited in chronic injury response or pathological metaplasia. Furthermore, candidate 
master regulators were identified controlling distinct cellular statuses using both expression analysis and 
protein activity analysis, which await further functional characterization and validation. 
Taken together, this thesis research provides insights into the origin and diversity of the adult stem cells 
in the respiratory tract, and the lineage relationships arising from responses to environmental agents.  
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